
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Osteopontin derived from hypoxia-induced M2 macrophages promotes osteosarcoma progression through modulation of EGR3/ISG15 signaling and RIG-I expression - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="15253B498AF22DC3053B49005525A6BD.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="transmed">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372297/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Journal of Translational Medicine">
<meta name="citation_title" content="Osteopontin derived from hypoxia-induced M2 macrophages promotes osteosarcoma progression through modulation of EGR3/ISG15 signaling and RIG-I expression">
<meta name="citation_author" content="Chunyang Xing">
<meta name="citation_author_institution" content="Department of Orthopedics, School of Medicine, First Affiliated Hospital of Zhejiang University, Qingchun Road No.79, Hangzhou, 310002 Zhejiang China">
<meta name="citation_author" content="Wei Hu">
<meta name="citation_author_institution" content="Department of Radiotherapy, Changxing County People’s Hospital, Huzhou, 313100 Zhejiang China">
<meta name="citation_author" content="Liyuan Zhao">
<meta name="citation_author_institution" content="Department of Emergency, Qilu Hospital of Shandong University, Jinan, 250014 Shandong China">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="23">
<meta name="citation_firstpage" content="950">
<meta name="citation_doi" content="10.1186/s12967-025-06936-y">
<meta name="citation_pmid" content="40841904">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372297/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372297/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372297/pdf/12967_2025_Article_6936.pdf">
<meta name="description" content="Osteosarcoma (OS) is one of the most common malignancies arising in bone. Hypoxia and immune regulation are pivotal in tumor biology. However, their combined effects and mechanisms in OS remain understudied. This study aimed to explore the role and ...">
<meta name="og:title" content="Osteopontin derived from hypoxia-induced M2 macrophages promotes osteosarcoma progression through modulation of EGR3/ISG15 signaling and RIG-I expression">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Osteosarcoma (OS) is one of the most common malignancies arising in bone. Hypoxia and immune regulation are pivotal in tumor biology. However, their combined effects and mechanisms in OS remain understudied. This study aimed to explore the role and ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372297/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12372297">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s12967-025-06936-y"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/12967_2025_Article_6936.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372297%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12372297/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12372297/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372297/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-transmed.png" alt="Journal of Translational Medicine logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Journal of Translational Medicine" title="Link to Journal of Translational Medicine" shape="default" href="https://translational-medicine.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">J Transl Med</button></div>. 2025 Aug 21;23:950. doi: <a href="https://doi.org/10.1186/s12967-025-06936-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s12967-025-06936-y</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22J%20Transl%20Med%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%20Transl%20Med%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J%20Transl%20Med%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22J%20Transl%20Med%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Osteopontin derived from hypoxia-induced M2 macrophages promotes osteosarcoma progression through modulation of EGR3/ISG15 signaling and RIG-I expression</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xing%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Chunyang Xing</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Chunyang Xing</span></h3>
<div class="p">
<sup>1</sup>Department of Orthopedics, School of Medicine, First Affiliated Hospital of Zhejiang University, Qingchun Road No.79, Hangzhou, 310002 Zhejiang China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xing%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Chunyang Xing</span></a>
</div>
</div>
<sup>1,</sup><sup>✉,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hu%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Wei Hu</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Wei Hu</span></h3>
<div class="p">
<sup>2</sup>Department of Radiotherapy, Changxing County People’s Hospital, Huzhou, 313100 Zhejiang China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hu%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Wei Hu</span></a>
</div>
</div>
<sup>2,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Liyuan Zhao</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Liyuan Zhao</span></h3>
<div class="p">
<sup>3</sup>Department of Emergency, Qilu Hospital of Shandong University, Jinan, 250014 Shandong China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhao%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Liyuan Zhao</span></a>
</div>
</div>
<sup>3</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Orthopedics, School of Medicine, First Affiliated Hospital of Zhejiang University, Qingchun Road No.79, Hangzhou, 310002 Zhejiang China </div>
<div id="Aff2">
<sup>2</sup>Department of Radiotherapy, Changxing County People’s Hospital, Huzhou, 313100 Zhejiang China </div>
<div id="Aff3">
<sup>3</sup>Department of Emergency, Qilu Hospital of Shandong University, Jinan, 250014 Shandong China </div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Feb 10; Accepted 2025 Jul 21; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12372297  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40841904/" class="usa-link">40841904</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p id="Par1">Osteosarcoma (OS) is one of the most common malignancies arising in bone. Hypoxia and immune regulation are pivotal in tumor biology. However, their combined effects and mechanisms in OS remain understudied. This study aimed to explore the role and mechanism of hypoxic-induced M2 macrophages in promoting the progression of OS.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p id="Par2">Differentially expressed proteins in hypoxic macrophage supernatants were detected by antibody array. Cell functional experiments, siRNA-mediated gene silencing, and overexpression transfection were used to study osteopontin (OPN) and its supernatant effect. Bioinformatics analysis was applied to investigate downstream targets and pathways, and a xenograft model was established to assess in vivo effects.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p id="Par3">Our data revealed that hypoxic M2 macrophage supernatant enhanced OS malignancy and epithelial-mesenchymal transition, activating cancer pathways. Hypoxia upregulated OPN in M2 macrophages, and OPN inhibition reduced its tumor-promoting effect. Early growth response 3 (EGR3) was differentially expressed in OS cells treated with the supernatant, and its overexpression inhibited OS cell migration, reversing tumor promotion. Interferon-stimulated gene 15 (ISG15), a key differentially expressed gene related to OPN and EGR3 overexpression, inhibited OS cell proliferation and migration. Additionally, OPN increased retinoic acid-inducible gene I (RIG-I) expression and enhanced signal transducer and activator of transcription 3, nuclear factor kappa B, and extracellular signal-regulated kinase signaling, while EGR3 and ISG15 overexpression inhibited these effects. Silencing ISG15 restored pathway activation and reversed the inhibitory effect of EGR3 on OS cell migration. Dual-Luciferase reporter gene assay confirmed that EGR3 activates ISG15 transcription. OPN treatment upregulated DNA (cytosine-5)-methyltransferase 1 (DNMT1) expression, and ChIP assays demonstrated that EGR3 overexpression enhanced DNMT1 binding to the EGR3 promoter. These findings suggest that OPN promotes OS malignancy by downregulating EGR3 and ISG15, and by enhancing RIG-I expression, as validated in a xenograft model of OS.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusion</h3>
<p id="Par4">Our findings demonstrate that hypoxic-induced M2 macrophages promote OS progression through OPN-dependent mechanisms, including inhibition of EGR3 and ISG15 expression and upregulation of RIG-I.</p></section><section id="sec5"><h3 class="pmc_sec_title">Graphical abstract</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372297_12967_2025_6936_Figa_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc0/12372297/4e316394dfe3/12967_2025_6936_Figa_HTML.jpg" loading="lazy" id="MO121" height="468" width="774" alt="graphic file with name 12967_2025_6936_Figa_HTML.jpg"></a></p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Osteosarcoma, Hypoxia, M2 macrophages, Osteopontin, EGR3, ISG15, RIG-I</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par46">Osteosarcoma (OS), the most common primary malignant bone tumor, shows a unique bimodal age distribution. The primary peak occurs in children and adolescents (median age of 18), and a second, smaller peak is observed in older adults over 60 years of age [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. OS mainly occurs in long bones like the femur, tibia, and humerus, near growth plates, and rarely in the skull, jaw, and pelvis, and is characterized by malignant osteoblastic cells producing osteoid matrix, a feature associated with aggressive behavior and high metastatic potential [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. While 68% of localized OS patients achieve 5 + years survival, 20–30% still develop metastasis or recurrence, and the prognosis for advanced cases has remained poor despite available anticancer therapies. [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>–<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. Therefore, uncovering the molecular mechanisms of OS progression and identifying reliable biomarkers is essential to advance precision oncology and immunotherapeutic strategies.</p>
<p id="Par47">Bone tumors, notably OS, develop within a unique bone tumor microenvironment (TME), which is a specialized and dynamic condition comprising bone cells (osteoclasts, osteoblasts, and osteocytes), stromal cells (mesenchymal stem cells and fibroblasts), vascular cells (endothelial cells and pericytes), immune cells (macrophages and lymphocytes), and a mineralized extracellular matrix (ECM) [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Under physiological conditions, a precise interplay between these cells maintains bone homeostasis, while in primary and secondary tumors, the bone TME provides a favorable microenvironment for tumor cell growth and progression [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. The crosstalk between OS and the bone TME encompasses an intricate network of environmental signals triggered by myriad cytokines, chemokines, and soluble growth factors [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. Hypoxia, a hallmark of the TME, reprograms gene and protein expression, contributing to tumor progression and poor prognosis [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>, <a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. For example, slowly proliferating cells in low-oxygen zones can resist cytotoxic drugs targeting fast-growing cells. In contrast, cancer stem cells may thrive there, facilitating epithelial-to-mesenchymal transition (EMT) and driving tumor progression [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>].</p>
<p id="Par48">Tumor-associated macrophages (TAMs) are a major immune cell group within the TME and can account for up to 50% of the cellular content in certain solid tumors [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. They promote disease progression and therapy resistance by supplying nutrients and growth factors to malignant cells. TAMs exhibit significant heterogeneity across cancer patients, lesions, and tumors. This arises from their ability to adapt to the environment, adopting diverse phenotypes, metabolism, and functions, ranging from pro-inflammatory M1-like to anti-inflammatory M2-like states [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. TAMs exhibit significant heterogeneity shaped by the complex TME, with hypoxia acting as a key driver that recruits TAMs to low-oxygen regions and promotes their polarization toward tumor-supportive phenotypes. For instance, studies have found that hypoxic niches drive TAM immunosuppression—a process exacerbated by vascular abnormalities induced by adaptive immunity in glioblastoma. Targeting these niches can disrupt TAM organization and improve tumor control [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. Hypoxia also alters tumor-macrophage communication, favoring M2 polarization, which boosts tumor growth, angiogenesis, and immune suppression, unlike M1 macrophages, which inhibit tumors. For example, activation of hypoxia-inducible factor-1α (HIF-1α) and HIF-2α is one of the main initiators of macrophage-head and neck squamous cell carcinoma cell interactions [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. Additionally, hypoxia regulates the communication between TAMs and tumor cells by influencing the expression and release of mediators such as extracellular vesicles, cytokines, and growth factors. These interactions are crucial for tumor survival, proliferation, and invasion [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>].</p>
<p id="Par49">Increasing evidence has shown that hypoxia or the immune microenvironment plays a vital role in the development of OS [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>–<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. However, reliable gene signatures based on the combination of hypoxia and the immune status for OS prognostic prediction have not been identified. This study aims to identify gene expression and biomarkers associated with both hypoxia and immune status and provide novel insights into the molecular mechanisms underlying the progression of OS.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Isolation and differentiation of bone marrow-derived macrophages (BMDMs)</h3>
<p id="Par50">Bone marrow-derived macrophages (BMDMs) were generated from BALB/c mice aged 6 to 8 weeks, which were obtained from Shanghai SLAC Laboratory Animal Co., Ltd. (License No. SCKK 2022-0004). Following euthanasia via cervical dislocation, femurs and tibias were collected under sterile conditions. After removing surrounding muscle tissues, both ends of the bones were excised, and the bone marrow was flushed out using a 1 mL syringe. The resulting suspension was passed through a 70 μm filter to eliminate tissue debris. Subsequently, red blood cell lysis buffer (2–3 mL) was applied to eliminate erythrocytes. Cells were pelleted by centrifugation at 300 × g for 5 min, and the resulting pellet was resuspended in complete Roswell Park Memorial Institute 1640 medium (RPMI-1640 medium containing 10% fetal bovine serum (FBS, s-FBS-x-015, SERANA, China) and 1% penicillin/streptomycin (P/S, 15140-122, Gibco, USA). For macrophage differentiation, cells were seeded at 1.5 × 10<sup>6</sup> per dish in a medium supplemented with 10 ng/mL macrophage colony-stimulating factor (M-CSF, HY-<a href="https://www.ncbi.nlm.nih.gov/protein/P70553" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">P70553</a>, MCE, USA). Cultures were maintained at 37℃ in an incubator with 5% CO<sub>2</sub> and high humidity. On the third day, half of the medium was replaced with fresh medium, followed by complete medium replenishment on day 5. By day 7, the adherent macrophage population was collected and designated mature BMDMs for subsequent assays.</p></section><section id="Sec4"><h3 class="pmc_sec_title">Cell culture</h3>
<p id="Par51">The cell lines HOS (YDT-0265), MG-63 (YDT-0400), THP-1 (YDT-0666), K7M2 (YDT-0317), and 293T (YDT-0019) utilized in this study were procured from INDIT Bio-Technology Co., Ltd (Hangzhou, China). The HOS and 293T cell lines were cultivated in Minimum Essential Medium (MEM, C11095500BT, BDBIO, China), while Dulbecco’s Modified Eagle Medium (DMEM, 02-5062EJ, BDBIO, China) was used to maintain MG-63 and K7M2 cells. The THP-1 cell line was grown in RPMI-1640. All cultures were incubated at 37 °C in a humidified atmosphere containing 5% carbon dioxide, and all media were supplemented with 10% fetal bovine serum and 1% penicillin–streptomycin.</p>
<p id="Par52">Cells under hypoxic conditions were cultured in a tri-gas incubator (1% O<sub>2</sub>, 5% CO<sub>2</sub>, 94% N<sub>2</sub>) to simulate a low-oxygen environment. Normoxic conditions were maintained at 21% O<sub>2</sub> and 5% CO<sub>2</sub>. These oxygen levels were strictly controlled and consistently applied across all experiments involving normoxia-hypoxia comparisons.</p></section><section id="Sec5"><h3 class="pmc_sec_title">
<em>Induction of M1-type macrophages </em>in vitro</h3>
<p id="Par53">THP-1 cells underwent differentiation into M0 macrophages following 24 h exposure to 100 ng/mL phorbol 12-myristate 13-acetate (PMA, HY-18739, MCE, USA). Following a 24 h recovery in a fresh complete medium, cells were cells were treated with 100 ng/mL lipopolysaccharide (LPS, L2630, Sigma, USA) and 20 ng/mL interferon-γ (IFN-γ, HY-P7025A, MCE, USA) for 48 h to drive M1 polarization.</p></section><section id="Sec6"><h3 class="pmc_sec_title">
<em>Induction of M2-type macrophages </em>in vitro</h3>
<p id="Par54">To induce M2-type polarization, THP-1 cells were initially treated with 100 ng/mL PMA for 24 h to facilitate differentiation. Subsequently, the cells were incubated for 48 h with 10 ng/mL of Interleukin-4 (IL-4, 200-04-20UG, PEPROTECH, China) and Interleukin-13 (IL-13, 200-13-10UG, PEPROTECH, China). BMDMs were polarized to the M2 phenotype by treatment with 20 ng/mL IL-4 and 20 ng/mL IL-13 for 24 h.</p></section><section id="Sec7"><h3 class="pmc_sec_title">Macrophage-OS coculture assay</h3>
<p id="Par55">To investigate the function of hypoxic tumor-associated macrophages (TAMs) in the progression of OS, human THP-1-derived macrophages were induced and polarized into both M1 and M2 subtypes under normoxic (21% O<sub>2</sub>) and hypoxic (1% O<sub>2</sub>) conditions, while primary mouse BMDMs were polarized into the M2 subtype under the same conditions. The supernatant from M2 macrophages was co-cultured with OS cell lines for an additional 24 h to assess its impact on the malignant phenotypes of OS cells.</p></section><section id="Sec8"><h3 class="pmc_sec_title">Methylthiazolyl diphenyltetrazolium bromide (MTT) assay</h3>
<p id="Par56">HOS, MG-63, and K7M2 cell lines were plated in 96-well plates at a density of 1 × 10<sup>4</sup> cells per well. After 24 h of incubation, MTT (M2128, Sigma, USA) was added to each well, and the cells were incubated for an additional 3 h. Following incubation, the formazan produced was solubilized using dimethyl sulfoxide (DMSO, D2650, Sigma, USA). The absorbance at 570 nm was recorded using a microplate reader (51,119,570, Thermo Fisher, USA) to assess cell viability.</p></section><section id="Sec9"><h3 class="pmc_sec_title">Transwell assay</h3>
<p id="Par57">HOS, MG-63, and K7M2 cells were collected and seeded in the upper Transwell chamber (3422, COSTAR, USA) at a density of 1 × 10<sup>4</sup> cells per well without adding serum. A culture medium supplemented with 10% FBS was added to the lower Transwell chamber. After 24 h of culture, the cells were fixed with methanol and stained with crystal violet (C110703, Aladdin, China). Invasion assays were performed by adding Matrigel (356,234, Corning, USA) to the upper chamber half an hour in advance. Cell migration and invasion were observed and imaged using a microscope (IX73, Olympus Corp, China).</p></section><section id="Sec10"><h3 class="pmc_sec_title">Colony formation assay</h3>
<p id="Par58">HOS, MG-63, and K7M2 cells were seeded in 96-well plates at a density of 5 × 10<sup>5</sup> cells per well. After cell adhesion, the medium was carefully removed, and cells were fixed with 4% paraformaldehyde (1 mL per well) for 30 min. Cells were then stained with 1% crystal violet solution (1 mL per well) for 20 min to visualize colonies. Colonies containing more than 50 cells were considered viable and counted under an inverted microscope (ECLIPSE Ts2, Nikon, Japan). Colony images were captured and analyzed using ImageJ software (v1.8.0).</p></section><section id="Sec11"><h3 class="pmc_sec_title">Western blotting (WB) analysis</h3>
<p id="Par59">Cell lysates were generated using RIPA buffer, and protein concentrations were determined with a bicinchoninic acid (BCA) assay kit (PC0020, Solarbio, China). WB was performed in accordance with the published description [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>]. The protein samples were separated using SDS–polyacrylamide gel electrophoresis and subsequently transferred to a polyvinylidene difluoride (PVDF) membrane. The ECL kit (BL520B, Biosharp, China) was used to visualize those specifically bound to primary and secondary antibodies. The primary antibodies used in this experiment are listed in Table <a href="#Tab1" class="usa-link">1</a>.</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Details of antibodies</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Name</th>
<th align="left" colspan="1" rowspan="1">Brand</th>
<th align="left" colspan="1" rowspan="1">Number</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">β-actin</td>
<td align="left" colspan="1" rowspan="1">CST</td>
<td align="left" colspan="1" rowspan="1">4970</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HIF1A</td>
<td align="left" colspan="1" rowspan="1">Abcam</td>
<td align="left" colspan="1" rowspan="1">ab179483</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">E-cadherin</td>
<td align="left" colspan="1" rowspan="1">Proteintech</td>
<td align="left" colspan="1" rowspan="1">20,874-1-AP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">N-cadherin</td>
<td align="left" colspan="1" rowspan="1">Abclonal</td>
<td align="left" colspan="1" rowspan="1">A19083</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Vimentin</td>
<td align="left" colspan="1" rowspan="1">Abclonal</td>
<td align="left" colspan="1" rowspan="1">A19607</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">p-STAT3</td>
<td align="left" colspan="1" rowspan="1">CST</td>
<td align="left" colspan="1" rowspan="1">9145S</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">STAT3</td>
<td align="left" colspan="1" rowspan="1">Proteintech</td>
<td align="left" colspan="1" rowspan="1">10,253-2-AP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">p-AKT</td>
<td align="left" colspan="1" rowspan="1">CST</td>
<td align="left" colspan="1" rowspan="1">4060s</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">AKT</td>
<td align="left" colspan="1" rowspan="1">Proteintech</td>
<td align="left" colspan="1" rowspan="1">60,203-2-lg</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">p-P13K</td>
<td align="left" colspan="1" rowspan="1">CST</td>
<td align="left" colspan="1" rowspan="1">4228</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">P13K</td>
<td align="left" colspan="1" rowspan="1">Proteintech</td>
<td align="left" colspan="1" rowspan="1">60,225-1-Ig</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">p-ERK</td>
<td align="left" colspan="1" rowspan="1">CST</td>
<td align="left" colspan="1" rowspan="1">p-ERK</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ERK</td>
<td align="left" colspan="1" rowspan="1">Proteintech</td>
<td align="left" colspan="1" rowspan="1">16,443-1-AP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">p-NFκB</td>
<td align="left" colspan="1" rowspan="1">CST</td>
<td align="left" colspan="1" rowspan="1">3033S</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">NFκB</td>
<td align="left" colspan="1" rowspan="1">CST</td>
<td align="left" colspan="1" rowspan="1">#8242</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">OPN</td>
<td align="left" colspan="1" rowspan="1">Abcam</td>
<td align="left" colspan="1" rowspan="1">ab69498</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">EGR3</td>
<td align="left" colspan="1" rowspan="1">Abcam</td>
<td align="left" colspan="1" rowspan="1">ab232820</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">RIG-I</td>
<td align="left" colspan="1" rowspan="1">Santa Cruz</td>
<td align="left" colspan="1" rowspan="1">sc-376845</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PD-L1</td>
<td align="left" colspan="1" rowspan="1">CST</td>
<td align="left" colspan="1" rowspan="1">13684T</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ISG15</td>
<td align="left" colspan="1" rowspan="1">Sigma</td>
<td align="left" colspan="1" rowspan="1">HPA004627</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">DNMT1</td>
<td align="left" colspan="1" rowspan="1">CST</td>
<td align="left" colspan="1" rowspan="1">5032</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Anti-mouse IgG</td>
<td align="left" colspan="1" rowspan="1">CST</td>
<td align="left" colspan="1" rowspan="1">7076P2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Anti-rabbit IgG</td>
<td align="left" colspan="1" rowspan="1">CST</td>
<td align="left" colspan="1" rowspan="1">7074P2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HRP-conjugated anti-mouse IgG</td>
<td align="left" colspan="1" rowspan="1">Servicebio</td>
<td align="left" colspan="1" rowspan="1">G1214</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HRP-conjugated anti-rabbit IgG</td>
<td align="left" colspan="1" rowspan="1">Servicebio</td>
<td align="left" colspan="1" rowspan="1">G1213</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec12"><h3 class="pmc_sec_title">Cytokine antibody array analysis</h3>
<p id="Par60">To identify differentially expressed proteins in the supernatant of THP-1 cells differentiated into M2 macrophages and treated under hypoxic conditions for 24 h, the supernatant was collected and centrifuged to remove cellular debris, and samples were diluted as required. Cytokine and chemokine expression was assessed using the Human Cytokine Antibody Array (ab133998, Abcam, UK), a multiplexed, semi-quantitative array designed to simultaneously detect and quantify multiple cytokines and chemokines in a single sample. The antibody array membrane was initially blocked with 1 × blocking buffer for 30 min at room temperature to prevent non-specific binding. Subsequently, diluted supernatant samples were added to the array and incubated for 2 h at room temperature. After a series of buffer washes, biotin-conjugated secondary antibodies were applied, followed by a 2 h incubation at room temperature. Additional washes were performed before adding HRP-conjugated streptavidin, with a further incubation of 2 h at room temperature. Finally, the membranes were visualized using a chemiluminescence detection system to compare signal intensities at specific antigen–antibody spots, determining relative protein expression levels among the samples. Signal intensity was quantified using ImageLab software.</p></section><section id="Sec13"><h3 class="pmc_sec_title">Real-Time quantitative polymerase chain reaction (RT-qPCR)</h3>
<p id="Par61">Cells were lysed using Trizol reagent (15,596,018, Ambion, China) to extract total RNA. RNA extraction was performed using isopropanol (327,270,010, Acros Organics, USA), followed by a 75% ethanol wash, and then dissolved in Diethyl pyrocarbonate (DEPC)-treated water (BL510B, Biosharp, China). The subsequent procedures were performed using the RevertAid First Strand cDNA Synthesis Kit (K1622, Thermo, USA) following the manufacturer's instructions. RT-qPCR amplification was conducted on a Thermo 7300 RT-qPCR system with the Genious™ 2 × SYBR Green Fast qPCR Mix (RM21204, Abclonal, China). Relative mRNA expression levels were calculated using the 2<sup>−ΔΔCt</sup> method, with β-actin as the reference gene. RT-qPCR was performed using optimized primer pairs and commercial SYBR Green reagents under conditions recommended by the manufacturer. Only Ct values within the accepted linear range were included in the analysis. The primer sequences can be found in Table <a href="#Tab2" class="usa-link">2</a>.</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>The sequences of RNA primers</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Names</th>
<th align="left" colspan="1" rowspan="1">Forward(5′-3′)</th>
<th align="left" colspan="1" rowspan="1">Reverse(5′-3′)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">β-actin</td>
<td align="left" colspan="1" rowspan="1">AGCAGTTGTAGCTACCCGCCCA</td>
<td align="left" colspan="1" rowspan="1">GGCGGGCACGTTGAAGGTCT</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">OPN</td>
<td align="left" colspan="1" rowspan="1">AAAATAGAGCTGCCTTGGGGG</td>
<td align="left" colspan="1" rowspan="1">GGCTTTCGTTGGACTTACTTGG</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ENO4</td>
<td align="left" colspan="1" rowspan="1">CGATTTGGCTGTTGGGCTTG</td>
<td align="left" colspan="1" rowspan="1">CCTGTTTCGGCTGATTCCTCT</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GRIN3B</td>
<td align="left" colspan="1" rowspan="1">TTCAGTATCAACTCCGCCCG</td>
<td align="left" colspan="1" rowspan="1">GAAGAGGATGGCGTAGCACA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">WNT11</td>
<td align="left" colspan="1" rowspan="1">ACTGAACCAGACGCAACACT</td>
<td align="left" colspan="1" rowspan="1">GGTCCCTCTCTCCAGGTCAA</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">DLX5</td>
<td align="left" colspan="1" rowspan="1">ACTTTGCCCGAGTCTTCAGC</td>
<td align="left" colspan="1" rowspan="1">TCTTTCTCTGGCTGGTTGGT</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">EGR3</td>
<td align="left" colspan="1" rowspan="1">TGCCTGACAATCTGTACCCC</td>
<td align="left" colspan="1" rowspan="1">TCCCAAGTAGGTCACGGTCT</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">BATF2</td>
<td align="left" colspan="1" rowspan="1">CCCAAGGAGCAACAAAGGC</td>
<td align="left" colspan="1" rowspan="1">GCTGAGCAGGAGGCACAAT</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ISG15</td>
<td align="left" colspan="1" rowspan="1">GACCTGACGGTGAAGATGCTG</td>
<td align="left" colspan="1" rowspan="1">TGCTGCGGCCCTTGTTAT</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">TRIM5</td>
<td align="left" colspan="1" rowspan="1">GACAAGATACCAGACATT</td>
<td align="left" colspan="1" rowspan="1">CTCCTTCCTCTAACCCTAT</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PTPN7</td>
<td align="left" colspan="1" rowspan="1">AGGTCACCCTACACTTTCTGC</td>
<td align="left" colspan="1" rowspan="1">CTCCTTCCCGTCATAGCC</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec14"><h3 class="pmc_sec_title">ELISA quantification of osteopontin (OPN)</h3>
<p id="Par62">To evaluate the levels of OPN in the supernatant of THP-1 cells that had been induced to the M2 phase and subjected to hypoxic treatment, we employed an ELISA kit (EK2135, MultiSciences, China). The process commenced with the addition of 50 μL of diluent to each well of the microplate, which was then followed by the introduction of 50 μL of either the standard, control, or sample. The plate was left to incubate at room temperature for a duration of 2 h. After this, the plate underwent four washes before a conjugate reagent was applied to each well, with further incubation at room temperature for 2 h. After another set of four washes, 100 μL of substrate solution was added to each well. The enzymatic reaction was halted after 30 min with the addition of the stop solution. Finally, the absorbance was determined at 450 nm using a spectrophotometer (840-297000, Thermo, USA).</p></section><section id="Sec15"><h3 class="pmc_sec_title">Cell transfection</h3>
<p id="Par63">The stable lentiviral constructs for early growth response 3 (EGR3) or interferon-stimulated gene 15 (ISG15) overexpression (Lenti-EGR3 and Lenti-ISG15), as well as for OPN knockdown (sh-OPN), along with their corresponding negative controls, were generated using 293 T cells. The overexpression plasmids were obtained from Suzhou Genewiz Biotechnology Co., Ltd., and the shRNA plasmids were sourced from Tsingke Biotechnology Co., Ltd. (Hangzhou, China). Plasmids and transfection reagent (Lipofectamine 2000, 11,668,019, Thermo, USA) were diluted in serum-free medium, combined, and allowed to incubate at room temperature for 15 min to form complexes. These complexes were subsequently added to the cell medium, mixed gently, and incubated at 37 °C with 5% CO<sub>2</sub> for 24 h.</p>
<p id="Par64">HOS and MG63 cells were cultured in a serum-free medium for 12 h before the start of the experiment. To construct HOS and MG63 cell lines overexpressing EGR3 and ISG15, plasmids overexpressing EGR3 (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_004430" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_004430</a>) and ISG15 (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_005101" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_005101</a>) were inserted into the pcDNA3.1 vector, which contains a CMV promoter commonly used to achieve high expression levels. For gene silencing, siRNAs targeting ISG15 and a negative control siRNA (siR-NC) were used. EGR3 or ISG15 and their corresponding empty control plasmids or siRNAs were transfected into the corresponding HOS or MG63 cells for 24 h using Lipofectamine 2000. The transfection efficiency was detected by WB. All plasmids were obtained from Youbio (Hunan, China). The sequences used in this experiment are listed in Table <a href="#Tab3" class="usa-link">3</a>.</p>
<section class="tw xbox font-sm" id="Tab3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Information of sequences for shRNA and siRNA</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Name</th>
<th align="left" colspan="1" rowspan="1">Sequences</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">sh-OPN-1</td>
<td align="left" colspan="1" rowspan="1">GATCGCCGGCCACAAGCAGTCCAGATTATACTCGAGTATAATCTGGACTGCTTGTGGTTTTTT</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">sh-OPN-NC</td>
<td align="left" colspan="1" rowspan="1">GATCGGTTCTCCGAACGTGTCACGTCTCGAGACGTGACACGTTCGGAGAACCTTTTTT</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">siR-ISG15</td>
<td align="left" colspan="1" rowspan="1">
<p>sense: CAUGUCGGUGUCAGAGCUGAA</p>
<p>antisense: UUCAGCUCUGACACCGACAUG</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">siR-ISG15-NC</td>
<td align="left" colspan="1" rowspan="1">
<p>sense: UUCUCCGAACGAGUCACGUTT</p>
<p>antisense: ACGUGACUCGUUCGGAGAATT</p>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec16"><h3 class="pmc_sec_title">Dual-Luciferase reporter gene assay</h3>
<p id="Par65">To evaluate the impact of wild-type OPN on promoter activity in a hypoxic environment, M2 macrophages (THP-1) were co-transfected with a luciferase reporter plasmid containing the wild-type human OPN promoter region (− 1000 to + 1) cloned into the pGL3-basic vector. The cells were cultured for 24 h in a hypoxic environment with normoxic (21% O<sub>2</sub>) or hypoxic (1% O<sub>2</sub>) conditions, lysed with 1 × lysis buffer, and then centrifuged to remove debris. Luciferase activity was measured in a 96-well plate using the Dual-Luciferase® Reporter Assay System (E1910, Promega, USA). LAR II and Stop &amp; Glo® Reagents were added sequentially, and relative luciferase units were calculated and normalized to the empty vector control.</p>
<p id="Par66">For assessing EGR3 transcriptional activation of ISG15, luciferase reporter constructs containing wild-type or mutant EGR3-binding sequences within the ISG15 promoter were generated. HOS cells were simultaneously transfected with reporter plasmids and either pcDNA3.1-EGR3 or an empty pcDNA3.1 vector. Luciferase activity was assessed 24 h after transfection.</p></section><section id="Sec17"><h3 class="pmc_sec_title">Chromatin immunoprecipitation (ChIP)</h3>
<p id="Par67">Cells were crosslinked with 1% formaldehyde, lysed, and chromatin was sheared using ultrasound. Overnight incubation of the sheared chromatin with a DNA (cytosine-5)-methyltransferase 1 (DNMT1)-specific antibody was followed by immunoprecipitation using protein G magnetic beads at 4 °C. After crosslink reversal and protein digestion with NaCl and Proteinase K at 65 °C for 2 h, DNA was purified for subsequent analysis. PCR amplification was performed using primers targeting the DNMT1-binding region within the EGR3 promoter (forward: 5′-CTTTCTAACTGCTGGGGTG-3′, reverse: 5′-CTATTTATCTGAGCCCCGG-3′).</p>
<section id="Sec18"><h4 class="pmc_sec_title">RNA extraction and library construction</h4>
<p id="Par68">Total RNA was isolated using Trizol (15,596,018, Ambion, USA) following the manufacturer's instructions. A NanoDrop ND-1000 was used to assess RNA concentration and purity, while an Agilent Bioanalyzer and agarose gel electrophoresis confirmed the integrity (RIN &gt; 7.0). From 1 µg of total RNA, Poly(A) RNA was extracted using Dynabeads Oligo(dT)25. The purified RNA was then fragmented at 94 °C for 5–7 min and converted to cDNA using SuperScript™ II. The second strand synthesis involved E. coli DNA polymerase I, RNase H, and dUTP. An adenine base was introduced to the cDNA for adapter ligation, and size selection was performed using AMPureXP beads. PCR amplification was performed under defined thermal conditions, resulting in an average insert size of 300 ± 50 bp. Paired-end sequencing of 150 bp was subsequently conducted on an Illumina NovaSeq™ 6000 (LC-Bio Technology, Hangzhou).</p></section></section><section id="Sec19"><h3 class="pmc_sec_title">Bioinformatics analysis of RNA-seq</h3>
<p id="Par69">For gene expression profiling, two independent RNA-seq analyses were conducted. In Fig. <a href="#Fig4" class="usa-link">4</a>, HOS cells were treated for 24 h with supernatants from THP-1-derived M2 macrophages cultured under hypoxic (1% O<sub>2</sub>) or normoxic (21% O<sub>2</sub>) conditions. In Fig. <a href="#Fig6" class="usa-link">6</a>, MG-63 cells were transfected with either a plasmid for EGR3 overexpression or a control vector, followed by recombinant OPN treatment.</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372297_12967_2025_6936_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc0/12372297/30f2695fcf6f/12967_2025_6936_Fig4_HTML.jpg" loading="lazy" id="d33e1190" height="459" width="797" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>DEGs and their enriched pathways were identified by bioinformatics analysis. HOS cells were treated with the supernatant from hypoxic M2 macrophages under hypoxic or normoxic conditions for 24 h, followed by HTS analysis to identify DEGs. <strong>A</strong> Bar chart of DEGs counts. <strong>B</strong> Volcano plot of DEGs. (<strong>C</strong>) A heatmap was utilized to visualize the significant DEGs. <strong>D</strong> and <strong>E</strong> The biological processes and pathways in which DEGs were enriched were identified by GO <strong>D</strong> and KEGG <strong>E</strong> enrichment analysis</p></figcaption></figure><figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig. 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372297_12967_2025_6936_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc0/12372297/f8902d8f1fba/12967_2025_6936_Fig6_HTML.jpg" loading="lazy" id="d33e1285" height="640" width="797" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Identified DEGs and enriched pathways in EGR3-transfected MG-63 cells with OPN treatment. MG-63 cells were transfected with EGR3 and combined with OPN treatment, followed by HTS analysis to identify DEGs. <strong>A</strong> Bar chart of DEGs counts. <strong>B</strong> Volcano plot of DEGs (upper panel: OPN_EGR3 vs. OPN; lower panel: OPN vs. pCDH). <strong>C</strong> A heatmap was utilized to visualize the significant DEGs (left panel: OPN_EGR3 vs. OPN; right panel: OPN vs. pCDH). <strong>D</strong> and <strong>E</strong> The biological processes and pathways in which DEGs were enriched were identified by GO (<strong>D</strong>) and KEGG (<strong>E</strong>) enrichment analysis (left panel: OPN_EGR3 vs. OPN; right panel: OPN vs. pCDH)</p></figcaption></figure><p id="Par70">Raw sequencing data were obtained in FASTQ format and subjected to quality control using FastQC. Adapter sequences and low-quality reads were removed using fastp (<a href="https://github.com/OpenGene/fastp" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/OpenGene/fastp</a>) to generate clean reads. Clean reads were aligned to the human reference genome using HISAT2 (<a href="https://ccb.jhu.edu/software/hisat2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://ccb.jhu.edu/software/hisat2</a>), and gene-level quantification was performed using featureCounts. Raw count matrices were normalized and analyzed for differential gene expression using DESeq2. Differentially expressed genes (DEGs) were defined using a threshold of |log<sub>2</sub>FC|≥ 1 and adjusted q-value &lt; 0.05. DEG statistics, including the number of upregulated and downregulated genes, were visualized using ggplot2 (<a href="https://github.com/gpertea/gffcompare/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/gpertea/gffcompare/</a>). Functional enrichment analyses for Gene Ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were conducted using the clusterProfiler R package, and the top 20 enriched pathways were presented. For the Hypoxia vs. Normoxia comparison, the top 100 DEGs (ranked by q-value) were selected for heatmap visualization using the pheatmap package, with expression values shown as Z-scores. For OPN_EGR3 vs. OPN and OPN vs. pCDH groups, heatmaps were similarly generated based on DEGs, with standardized expression displayed using Z-transformed values.</p></section><section id="Sec20"><h3 class="pmc_sec_title">Construction of the xenograft tumor models in vivo</h3>
<p id="Par71">Xenograft tumor models were established by subcutaneously injecting MG-63 cells with stable overexpression of EGR3 or ISG15 or control cells (5 × 10<sup>6</sup>/200 μL) into 5-week-old female nude mice (n = 6) obtained from Slaccas (Shanghai, China). The mice were assigned to six groups: Lenti-control + PBS, Lenti-EGR3 + PBS, Lenti-ISG15 + PBS, Lenti-control + OPN, Lenti-EGR3 + OPN, and Lenti-ISG15 + OPN. After tumor formation, the treatment group mice were administered 100 μL of a 150 μg/mL OPN solution through intratumoral injection twice a week, while the control group mice received an equivalent volume of PBS. All mice were kept under pathogen-free conditions with a 12 h light/dark cycle at 22°C for approximately one week before treatment. Tumor growth was closely monitored, and once the control group tumors reached a volume of 1500 mm<sup>3</sup>, all the mice were euthanized, tumors were stripped, and their volumes and weights were measured. The experimental procedures conducted in this study adhered strictly to the Chinese Regulations for the Administration of Laboratory Animals. The animal experiments were approved by the Laboratory of Animal Experimental Ethical Inspection of Dr. Can Biotechnology (Zhejiang) Co., Ltd. (Approval No. DRK-20240914021).</p></section><section id="Sec21"><h3 class="pmc_sec_title">Immunohistochemistry (IHC) assay</h3>
<p id="Par72">The expression of EGR3, ISG15, phosphorylated signal transducer and activator of transcription 3 (p-STAT3), phosphorylated nuclear factor kappa B (p-NFκB), and phosphorylated extracellular signal-regulated kinase (p-ERK) of the tumor tissues was determined by the IHC assay. After dewaxing and rehydration, longitudinal sections of 5 μm thickness were stained with hematoxylin for 5 min, followed by cytoplasmic staining with eosin. The sections were rinsed in distilled water for 30 s and then dehydrated using a graded alcohol series. Afterward, the sections were cleared with xylene and examined and photographed using a fluorescence microscope (BX53, Olympus). For immunohistochemistry, the sections were blocked with 3% BSA and incubated overnight with specific primary antibodies. Following this, they were treated with a secondary antibody at room temperature for 30 min. Staining was visualized using DAB (G1212, Servicebio), and counterstaining was performed with hematoxylin. Finally, three randomly selected fields were photographed under the microscope. The primary antibodies used in this experiment are listed in Table <a href="#Tab1" class="usa-link">1</a>.</p></section><section id="Sec22"><h3 class="pmc_sec_title">Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) assay</h3>
<p id="Par73">The TUNEL assay was performed on isolated xenograft tumors to detect apoptosis. Briefly, the tumors were paraffin-embedded and sectioned at a thickness of 5 μm. The tumor sections were stained using the TUNEL FITC Apoptosis Detection Kit (A111-01, Vazyme, China) according to the manufacturer's guidelines. Following this, the nuclei were stained with DAPI solution (C1002, Beyotime, China). The stained sections were then analyzed and photographed with a fluorescence microscope (BX53, Olympus, Japan).</p></section><section id="Sec23"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par74">Statistical analyses were conducted using SPSS version 18 (SPSS, Inc.) and GraphPad software 6.0. Measurement data were expressed as the mean ± standard deviation (SD). A two-tailed unpaired Student's t-test was employed for group comparisons, while one-way ANOVA followed by Tukey's post hoc test was utilized for comparisons among multiple groups. A <em>p</em>-value of less than 0.05 was deemed statistically significant.</p></section></section><section id="Sec24"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec25"><h3 class="pmc_sec_title">Hypoxic M2 macrophages promote malignant phenotypes in OS cells</h3>
<p id="Par75">To investigate the function of hypoxic TAMs in the progression of OS, we selected MG-63, HOS, and K2M7 cell lines for further study. These cell lines are widely used in OS research, with stable genetic profiles, and have been employed in studies related to metastasis, drug response, hypoxia, and hypoxia-driven signaling [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>, <a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]. Human THP-1-derived macrophages were polarized into both M1 and M2 subtypes under normoxic and hypoxic conditions. Primary mouse BMDMs were also polarized into the M2 subtype under the same conditions to assess their impact on the malignant phenotypes of OS cells. WB analysis was performed to assess HIF1A expression in K7M2 cells after co-culture with supernatants from primary mouse BMDMs polarized to the M2 phenotype under normoxic or hypoxic conditions. The results showed that HIF1A expression was significantly upregulated in K7M2 cells co-cultured with supernatants from hypoxic M2 macrophages, validating the induction of hypoxia (Fig. <a href="#Fig1" class="usa-link">1</a>A). Subsequently, we demonstrated that hypoxic M2 macrophage supernatants significantly promoted cell proliferation, migration, invasion, and colony formation in OS cells. In contrast, supernatants from M1 macrophages had no significant effect on cell migration and invasion (Fig. <a href="#Fig1" class="usa-link">1</a>B–E). The detection of epithelial-mesenchymal transition (EMT) pathway-related proteins indicated that hypoxic M2 macrophages enhanced the activity of the EMT pathway (Fig. <a href="#Fig1" class="usa-link">1</a>F). Furthermore, hypoxic M2 macrophages activated multiple cancer-related signaling pathways, including the STAT3, PI3K/Protein kinase B (AKT), Mitogen-activated protein kinase (MAPK)/ERK, and NFκB signaling pathways (Fig. <a href="#Fig1" class="usa-link">1</a>G). These findings suggested that hypoxic M2 macrophages play a significant role in the promotion of malignant phenotypes in OS cells.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372297_12967_2025_6936_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc0/12372297/273f8da5be00/12967_2025_6936_Fig1_HTML.jpg" loading="lazy" id="d33e1045" height="1139" width="797" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Hypoxic M2 macrophages promote malignant phenotypes in OS Cells. <strong>A</strong> WB assay was used to detect HIF1α expression in K7M2 cells after co-culture with supernatants from primary BMDMs polarized to the M2 phenotype under normoxic or hypoxic conditions. <strong>B</strong> MTT assay was used to examine the effect of hypoxic M2 macrophages on the proliferation of OS cells. <strong>C</strong> The effect of hypoxic M2 macrophages on the colony formation of OS cells. <strong>D</strong> Transwell assay was employed to test the migration and invasion capabilities of K7M2 cells co-cultured with M2 macrophages under normoxic and hypoxic conditions. <strong>E</strong> The migratory and invasive capabilities of HOS and MG-63 cells were assessed using Transwell assays in response to normoxic or hypoxic M0, M1, and M2 macrophages. <strong>F</strong> WB assay was used to detect the effect of hypoxic M2 macrophages on the expression of EMT pathway-related proteins in OS cells. <strong>G</strong> WB assay was used to detect the effect of hypoxic M2 macrophages on cancer-related signaling pathways, including STAT3, PI3K/AKT, ERK, and NFκB in OS cells. All data came from at least three replicate experiments. A value of <em>p</em> below 0.05 is considered significant, <sup>*</sup><em>p</em> &lt; 0.05, <sup>**</sup><em>p</em> &lt; 0.01 vs the control group</p></figcaption></figure></section><section id="Sec26"><h3 class="pmc_sec_title">Hypoxia promotes the polarization of M1 to M2 macrophages and upregulates OPN expression in M2 macrophage</h3>
<p id="Par76">To investigate the effect of hypoxia on M2 macrophage secretory profile, an antibody array was utilized to identify differentially expressed proteins in the supernatant of M2 macrophages with hypoxic treatment for 24 h. The results demonstrated there were eight significantly differentially expressed proteins, including epithelial-derived neutrophil-activating peptide 78 (ENA-78/CXCL5), growth-regulated oncogene (GRO/CXCL1), monocyte chemoattractant protein-1 (MCP-1/CCL2), macrophage-derived chemokine (MDC/CCL22), regulated on activation, normal T cell expressed and secreted (RANTES/CCL5), tumor necrosis factor-alpha (TNF-α), and tissue inhibitor of metalloproteinases-1 (TIMP-1), OPN (Fig. <a href="#Fig2" class="usa-link">2</a>A). Among these, OPN showed the most notable increase and was selected for further functional investigation based on its previously reported involvement in OS progression and immune modulation [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>, <a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. To corroborate the identification outcome derived from the antibody array, we further examined the levels of OPN in the supernatant and intracellular environment of hypoxic M2 macrophages. The results revealed an upregulation of OPN in both locations (Fig. <a href="#Fig2" class="usa-link">2</a>B,C). Consistently, the dual-luciferase reporter gene assay demonstrated that hypoxic treatment enhanced the fluorescence intensity of OPN in M2 macrophages (Fig. <a href="#Fig2" class="usa-link">2</a>D).</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372297_12967_2025_6936_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc0/12372297/1bd1f964349e/12967_2025_6936_Fig2_HTML.jpg" loading="lazy" id="d33e1097" height="1239" width="785" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Hypoxia upregulates OPN expression in M2 macrophages. <strong>A</strong> The antibody array was utilized to identify differentially expressed proteins in the supernatant of M2 macrophages after 24 h hypoxia or normoxia treatment. <strong>B</strong> ELISA kit was used to examine the levels of OPN in the supernatant of hypoxic M2 macrophages. <strong>C</strong> WB assay was used to detect the expression levels of OPN in the intracellular environment of hypoxic M2 macrophages. <strong>D</strong> Dual-luciferase reporter gene assay was used to detect the fluorescence intensity in THP-1 cells transfected with wild-type OPN combined with hypoxia or normoxia treatment. All data came from at least three replicate experiments. A value of <em>p</em> below 0.05 is considered significant, <sup>*</sup><em>p</em> &lt; 0.05, <sup>**</sup><em>p</em> &lt; 0.01 vs the control group</p></figcaption></figure></section><section id="Sec27"><h3 class="pmc_sec_title">Knockdown of OPN in M2 macrophages attenuates hypoxia-induced malignant phenotypes of OS cells</h3>
<p id="Par77">To gain a comprehensive understanding of the function of OPN within M2 macrophages in the progression of OS, OPN was knocked down in THP-1 cells (Fig. <a href="#Fig3" class="usa-link">3</a>A). The shRNA with the most effective knockdown, sh-OPN-1, was selected for utilization in the subsequent experiments. The results demonstrated that hypoxic M2 macrophages significantly facilitated cell proliferation, migration, and colony formation, whereas knockdown of OPN within M2 macrophages attenuated these effects (Fig. <a href="#Fig3" class="usa-link">3</a>B–D). This indicated that the tumor-promoting effects of hypoxia-treated M2 macrophages were achieved through OPN-dependent mechanisms, at least in part.</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372297_12967_2025_6936_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc0/12372297/bfcfe106baf2/12967_2025_6936_Fig3_HTML.jpg" loading="lazy" id="d33e1139" height="578" width="669" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Knockdown of OPN in M2 macrophages attenuates hypoxia-induced malignant phenotypes of OS cells. <strong>A</strong> WB assay was used to detect the knockdown efficiency of OPN in THP-1 cells. <strong>B</strong> MTT assay was used to examine the effect of OPN knockdown in M2 macrophages combined with hypoxic treatment on the proliferation of OS cells. <strong>C</strong> Transwell assay was used to examine the effect of OPN knockdown in M2 macrophages on the migration of OS cells after a 24 h hypoxia or normoxia treatment. <strong>D</strong> The effect of OPN knockdown in M2 macrophages on the colony formation of OS cells after a 24 h hypoxia or normoxia treatment. All data came from at least three replicate experiments. A value of<em> p</em> below 0.05 is considered significant, <sup>*</sup><em>p</em> &lt; 0.05, <sup>**</sup><em>p</em> &lt; 0.01 vs the control group</p></figcaption></figure></section><section id="Sec28"><h3 class="pmc_sec_title">OPN contributes to malignant phenotypes via EGR3 downregulation in OS cells</h3>
<p id="Par78">To further investigate the mechanisms underlying the tumor-promoting effects of hypoxic M2 macrophages, HOS cells were treated with the supernatant from THP-1-derived M2 macrophages cultured under hypoxic (1% O<sub>2</sub>) or normoxic (21% O<sub>2</sub>) for 24 h, followed by high-throughput sequencing (HTS) analysis to identify differentially expressed genes (DEGs). The results revealed a total of 124 upregulated genes and 136 downregulated genes among the DEGs (Fig. <a href="#Fig4" class="usa-link">4</a>A,B). A heatmap was utilized to visualize the significant DEGs (Fig. <a href="#Fig4" class="usa-link">4</a>C). Additionally, Gene Ontology (GO) enrichment analysis indicated that the DEGs were intimately involved in positive regulation of peptidyl-serine phosphorylation, oxygen carrier activity, and cytokine-mediated signaling pathway (Fig. <a href="#Fig4" class="usa-link">4</a>D). Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis indicated that the DEGs were predominantly enriched in pantothenate and CoA biosynthesis, TNF signaling pathway, cytokine-cytokine receptor interaction, and transcriptional misregulation in cancer (Fig. <a href="#Fig4" class="usa-link">4</a>E).</p>
<p id="Par79">After filtering the DEGs based on fold change and p-value, five genes were identified as worthy of further investigation: Enolase 4 (ENO4), Glutamate Receptor, Ionotropic, N-Methyl-D-Aspartate 3B (GRIN3B), Wnt Family Member 11 (WNT11), Distal-Less Homeobox 5 (DLX5), and Early Growth Response 3 (EGR3). The analysis of their expression levels revealed that EGR3 exhibited the most significant differential expression in HOS cells treated with the supernatant from hypoxic M2 macrophages, with a tendency towards downregulation (Fig. <a href="#Fig5" class="usa-link">5</a>A). Therefore, EGR3 was selected for further investigation. The results demonstrated that overexpression of EGR3 markedly suppressed the migratory capacity of OS cells (Fig. <a href="#Fig5" class="usa-link">5</a>B,C). Furthermore, overexpression of EGR3 resulted in a reduction in the migration of OS cells promoted by hypoxic M2 macrophages (Fig. <a href="#Fig5" class="usa-link">5</a>D). Importantly, the tumor-promoting effects of recombinant OPN were reversed by overexpression of EGR3 (Fig. <a href="#Fig5" class="usa-link">5</a>E). These findings suggested that OPN in hypoxic M2 macrophages promoted malignant phenotypes by inhibiting the expression of EGR3 in OS cells.</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372297_12967_2025_6936_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc0/12372297/23c69cf17a70/12967_2025_6936_Fig5_HTML.jpg" loading="lazy" id="d33e1239" height="762" width="797" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>OPN promotes malignant phenotypes by inhibiting EGR3 expression in OS cells. <strong>A</strong> RT-qPCR assay was used to detect the relative mRNA expression levels of the ENO4, GRIN3B, WNT11, DLX5, and EGR3 genes in HOS cells treated with the supernatant from hypoxic M2 macrophages. <strong>B</strong> WB assay was used to detect the overexpression efficiency of EGR3 overexpression in OS cells. <strong>C</strong> Transwell assay was used to examine the effect of EGR3 overexpression on the migration of OS cells. <strong>D</strong> Transwell assay was used to examine the effect of overexpression of EGR3 on the migration of OS cells induced by hypoxic M2 macrophages. <strong>E</strong> Transwell assay was used to examine the effect of EGR3 overexpression on the migration of recombinant OPN (100 ng/mL) treated OS cells. All data came from at least three replicate experiments. A value of <em>p</em> below 0.05 is considered significant, <sup>*</sup><em>p</em> &lt; 0.05, <sup>**</sup><em>p</em> &lt; 0.01 vs the control group</p></figcaption></figure></section><section id="Sec29"><h3 class="pmc_sec_title">OPN regulates EGR3, ISG15, and RIG-I expression and associated immune signaling in OS cells</h3>
<p id="Par80">As OPN was previously found to be upregulated in hypoxia-treated M2 macrophages, we further investigated whether recombinant OPN exerts a similar regulatory effect on immune-related gene expression in OS cells. MG-63 cells were transfected with either an EGR3 overexpression plasmid or a control vector, followed by treatment with OPN. Total RNA was extracted, and high-throughput sequencing was performed to identify DEGs. The results demonstrated that, in comparison between the control group and the OPN treatment group, there were 298 upregulated genes and 612 downregulated genes. In the comparison between the OPN treatment group and the EGR3-transfected plus OPN treatment group, there were 304 upregulated genes and 143 downregulated genes (Fig. <a href="#Fig6" class="usa-link">6</a>A,B). The heatmaps illustrated the gene expression data (Fig. <a href="#Fig6" class="usa-link">6</a>C). Subsequently, GO enrichment analysis revealed that the DEGs were predominantly enriched in various responses to viruses, immune system processes, innate immune response, protein binding, and interferon signaling pathways (Fig. <a href="#Fig6" class="usa-link">6</a>D). KEGG enrichment analysis demonstrated that the DEGs identified from both comparisons were closely associated with multiple signaling pathways, including the NOD-like receptor signaling pathway, Cytokine-cytokine receptor interaction, Toll-like receptor signaling pathway, TNF signaling pathway, NFκB signaling pathway, and RIG-I-like receptor signaling pathway (Fig. <a href="#Fig6" class="usa-link">6</a>E).</p>
<p id="Par81">Among the DEGs, four genes were identified as warranting further investigation: Basic Leucine Zipper ATF-Like Transcription Factor 2 (BATF2), Interferon-Stimulated Gene 15 (ISG15), Tripartite Motif Containing 5 (TRIM5), and Protein Tyrosine Phosphatase, Non-Receptor Type 7 (PTPN7). The assessment of the mRNA expression levels demonstrated that OPN treatment significantly downregulated the expression of these proteins (BATF2, ISG15, and TRIM5) in MG-63 cells. Overexpression of EGR3 reversed the inhibitory effects of OPN on these proteins (Fig. <a href="#Fig7" class="usa-link">7</a>A). Notably, ISG15 is known to be involved in the RIG-I-like (Retinoic acid-inducible Gene I-like) receptor signaling pathway [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. Given the results from 6E, the DEGs were enriched in the RIG-I signaling pathway. These results suggested that OPN in M2 macrophages and EGR3 in OS cells exerted their influence on the malignant phenotype of OS cells, potentially through the regulation of the RIG-I-like receptor signaling pathway via ISG15. These results suggested that OPN suppresses ISG15 and associated immune-related genes, while EGR3 overexpression reverses these effects, potentially influencing the malignant phenotype of OS cells via the RIG-I-like receptor signaling pathway.</p>
<figure class="fig xbox font-sm" id="Fig7"><h4 class="obj_head">Fig. 7.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372297_12967_2025_6936_Fig7_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc0/12372297/ab517dafd0b3/12967_2025_6936_Fig7_HTML.jpg" loading="lazy" id="d33e1350" height="496" width="797" alt="Fig. 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>OPN promotes OS cell growth and alters the expression of EGR3, ISG15, and RIG-I, potentially affecting RIG-I-like receptor signaling. <strong>A</strong> RT-qPCR assay was used to detect mRNA levels of BATF2, ISG15, TRIM5, and PTPN7 in MG-63 cells with EGR3 overexpression and OPN treatment. <strong>B</strong> WB assay was used to detect the expression levels of ISG15, RIG-I, and PD-L1 in OS cells after OPN treatment. <strong>C</strong> WB assay was used to examine the effect of EGR3 overexpression on the expression levels of ISG15, RIG-I, and PD-L1 in OS cells. <strong>D</strong> WB assay evaluated the effect of ISG15 overexpression on the expression levels of RIG-I, PD-L1, STAT3, NFκB, PI3K, and ERK in OS cells. <strong>E</strong> MTT assay was used to examine the effect of overexpression of ISG15 on the proliferation of OS cells. <strong>F</strong> Transwell assay was used to examine the effect of overexpression of ISG15 on the migration of OS cells. <strong>G</strong> WB assay was used to examine the effect of overexpression of EGR3 combined with OPN treatment on the expression levels of STAT3, NFκB, PI3K, and ERK signaling pathway proteins in OS cells. <strong>H</strong> WB assay was used to examine the effect of EGR3 overexpression combined with ISG15 knockdown on the expression levels of ISG15, RIG-I, PD-L1, STAT3, NFκB, ERK, and PI3K signaling pathway proteins in OS cells. <strong>I</strong> Transwell assay was used to assess the migration capacity of HOS cells with EGR3 overexpression and ISG15 knockdown. <strong>J</strong> Dual-luciferase reporter gene assay was used to detect the fluorescence intensity in HOS cells transfected with wild-type or mutant ISG15 and EGR3 overexpression. <strong>K</strong> WB assay was used to detect DNMT1 expression in HOS cells stimulated with recombinant OPN. <strong>L</strong> ChIP assay evaluated DNMT1 binding to the EGR3 promoter. All data came from at least three replicate experiments. A value of <em>p</em> below 0.05 is considered significant, <sup>*</sup><em>p</em> &lt; 0.05, <sup>**</sup><em>p</em> &lt; 0.01 vs the control group</p></figcaption></figure><p id="Par82">ISG15 is a ubiquitin-like protein that modifies target proteins through ISGylation [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>, <a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. It has been reported that RIG-I, a key protein in the RIG-I-like receptor signaling pathway, is ISGylated by the ISG15 E3 ligase [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>, <a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>, <a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. Additionally, RIG-I can enhance the stability of PD-L1 through post-translational modifications [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. The results demonstrated that OPN treatment reduced the expression of ISG15 while upregulating the expression levels of RIG-I and PD-L1 (Fig. <a href="#Fig7" class="usa-link">7</a>B). Conversely, overexpression of EGR3 exerted the opposite effect on these proteins (Fig. <a href="#Fig7" class="usa-link">7</a>C). These findings suggested that OPN may modulate RIG-I-like receptor signaling in OS cells through coordinated changes in the expression of EGR3, ISG15, and RIG-I.</p>
<p id="Par83">It has been reported that the RIG-I-like receptor signaling pathway plays a role in regulating tumor cell survival, proliferation, and immune evasion by activating downstream pathways such as NFκB, STAT3, and ERK/MAPK [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>–<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. In our study, ISG15 overexpression in OS cells was associated with reduced RIG-I protein expression and decreased activation of its downstream signaling components, including STAT3, NFκB, PI3K, and ERK (Fig. <a href="#Fig7" class="usa-link">7</a>D). Furthermore, overexpression of ISG15 inhibited cell proliferation and migration in OS cells (Fig. <a href="#Fig7" class="usa-link">7</a>E,F). Importantly, OPN treatment led to reduced ISG15 levels and upregulation of RIG-I, along with enhanced phosphorylation of STAT3, NFκB, ERK, and PI3K. Conversely, the tumor-promoting effects of OPN were reversed by overexpression of EGR3 (Fig. <a href="#Fig7" class="usa-link">7</a>G).</p>
<p id="Par84">To further investigate the impact of EGR3 on these pathways, WB analysis showed that EGR3 overexpression significantly upregulated ISG15 expression and concurrently inhibited downstream signaling pathways, including phosphorylation of STAT3, NFκB, ERK, and PI3K. Silencing ISG15 restored the activation of these pathways (Fig. <a href="#Fig7" class="usa-link">7</a>H). Transwell assays demonstrated that knockdown of ISG15 reversed the inhibitory effect of EGR3 overexpression on OS cell migration (F<a href="#Fig7" class="usa-link">7</a>g. <a href="#Fig7" class="usa-link">7</a>I). Dual-Luciferase reporter gene assay confirmed that EGR3 transcriptionally activates ISG15 expression by binding to its promoter (Fig. <a href="#Fig7" class="usa-link">7</a>J). Additionally, OPN treatment markedly increased the protein expression of DNMT1, a key maintenance DNA methyltransferase [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>], in OS cells (Fig. <a href="#Fig7" class="usa-link">7</a>K), suggesting a potential epigenetic regulatory mechanism. ChIP assays further demonstrated that EGR3 overexpression enhanced DNMT1 binding to the EGR3 promoter, indicating that DNMT1 contributes to the transcriptional repression of EGR3 through promoter methylation (Fig. <a href="#Fig7" class="usa-link">7</a>L). Taken together, these findings suggested that OPN exerted a pro-cancer effect on OS cells by suppressing EGR3 and ISG15, thereby increasing RIG-I expression and activating downstream signaling pathways.</p></section><section id="Sec30"><h3 class="pmc_sec_title">OPN promotes OS tumor growth in vivo accompanied by downregulation of EGR3 and ISG15</h3>
<p id="Par85">To validate the role and mechanism of OPN in vivo, the xenograft tumor models were constructed with MG-63 cells. Consistent with the results from cell experiments in vitro, OPN treatment promoted tumor growth in vivo, while the overexpression of EGR3 or ISG15 effectively reversed the pro-cancer effects of OPN (Fig. <a href="#Fig8" class="usa-link">8</a>A and <a href="#Fig8" class="usa-link">8</a>). The results of apoptosis assays on tumor samples demonstrated that OPN treatment inhibited tumor cell apoptosis in OS, whereas overexpression of EGR3 or ISG15 promoted apoptosis and attenuated the inhibitory effect of OPN (Fig. <a href="#Fig8" class="usa-link">8</a>C). IHC analysis of relevant indicators in tumor samples demonstrated that OPN treatment results in a decrease in the expression of EGR3 and ISG15, while significantly increasing the levels of p-STAT3, p-NFκB, and p-ERK. Conversely, overexpression of EGR3 or ISG15 has been observed to diminish the upregulation of these markers induced by OPN (Fig. <a href="#Fig8" class="usa-link">8</a>D). This is consistent with our cellular findings, in which OPN treatment was associated with enhanced activation of the STAT3, NFκB, and ERK/MAPK signaling pathways, accompanied by downregulation of EGR3 and ISG15 in OS cells.</p>
<figure class="fig xbox font-sm" id="Fig8"><h4 class="obj_head">Fig. 8.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372297_12967_2025_6936_Fig8_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dc0/12372297/ada353f6104e/12967_2025_6936_Fig8_HTML.jpg" loading="lazy" id="d33e1467" height="445" width="797" alt="Fig. 8"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig8/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>OPN promoted tumor growth in vivo by downregulating EGR3 and ISG15 expression in OS. Mice were subcutaneously inoculated with MG-63 cells (5 × 10<sup>6</sup>/200 μL). When the tumor volume reached 100 mm<sup>3</sup>, mice were randomly divided into six groups: Lenti-control + PBS, Lenti-EGR3 + PBS, Lenti-ISG15 + PBS, Lenti-control + OPN, Lenti-EGR3 + OPN, and Lenti-ISG15 + OPN, with six mice in each group. Treatment group mice received 100 μL of 150 μg/mL OPN via intratumoral injection while control group mice received an equivalent volume of saline solution. <strong>A</strong> and <strong>B</strong> When the tumors reached a volume of 1500 mm<sup>3</sup>, tumor tissues were isolated from the mice and then the size (<strong>A</strong>), volume, and weight of the tumors (<strong>B</strong>) were recorded. <strong>C</strong> TUNEL assay was used to detect the apoptotic cells in tumor tissue (n = 3). The images are magnified 400 × and 800 ×. <strong>D</strong> IHC assay was used to detect the changes in the levels of EGR3, ISG15, p-STAT3, p-NFκB, and p-ERK protein in tumor tissues (n = 3). The images are magnified 200 × and 400 ×. The scale has been marked on the diagram</p></figcaption></figure><p id="Par86">In summary, this study demonstrated that hypoxia-induced OPN in M2 macrophages contributes to OS progression by altering the expression of EGR3, ISG15, and RIG-I, thereby modulating RIG-I-like receptor signaling and activating multiple downstream tumor-related pathways.</p></section></section><section id="Sec31"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par87">Recently, OS has become well-known for highly aggressive bone tumors with an elevated tendency of metastasis [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. The emerging evidence highlights the role of hypoxia or the immune microenvironment in OS progression, reflecting the complex interplay behind tumor aggressiveness and treatment difficulties [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>, <a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. Despite knowing the OS immune evasion and tumor hypoxia's poor prognosis link, current studies mainly focus on analyzing and predicting this relationship [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>, <a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>], and their underlying mechanisms are unclear. With the development of bioinformatics and HTS technology, many aberrantly expressed oncogenes have been identified and can serve as prognostic signatures for OS [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>–<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. However, these single-characteristic-based prognostic signatures fail to adequately reflect OS's disease features, and reliable gene signatures combining hypoxia and immune status for OS remain unidentified. Here, our findings have provided compelling evidence that hypoxia stimulated the expression of OPN in M2 macrophage supernatants, which in turn inhibited the expression of EGR3 and promoted the malignant phenotype of OS through the RIG-I-like receptor signaling pathway and immune evasion of PD-L1. Our findings highlight the contribution of the hypoxia-immune microenvironment to OS progression and offer new perspectives on its potential regulatory interactions.</p>
<p id="Par88">Immune evasion plays a critical role in OS progression by enabling tumor cells to escape immune surveillance.. Studies indicate that OS cells can upregulate CD47 to inhibit macrophage phagocytosis and express PD-L1 to suppress T cell activity via PD-1 interaction [<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>, <a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. Additionally, TME remodeling and impaired antigen presentation further contribute to immune evasion in OS [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>, <a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>]. Tumor hypoxia is another important factor in OS progression, promoting angiogenesis, metastasis, and resistance to therapy by activating various signaling pathways. For instance, hypoxia has been shown to upregulate vascular endothelial frowth factor (VEGF) expression via stabilization of HIF-1α, thereby facilitating angiogenesis and tumor progression in OS cells [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. In addition, hypoxia-mediated downregulation of spindle and kinetochore-associated complex subunit 1 (SKA1) has been associated with increased chemoresistance in OS [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>]. These findings underscore that immune response or tumor hypoxia is important for OS cell growth and metastasis. In this study, we were surprised to find that hypoxic-treated M2 macrophage supernatant promoted the malignant phenotype of OS cell lines, which was consistent with the first research to preliminarily establish a prognostic signature based on hypoxia and immune response in OS cells [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. To validate hypoxia in our model, we confirmed HIF1A upregulation in OS cells treated with supernatants from hypoxia-exposed M2 macrophages. Unexpectedly, HIF1A was also detectable under normoxia. This may result from M2-derived cytokines (e.g., IL-10, TGF-β, VEGF) activating PI3K/AKT and NFκB pathways, which enhance HIF1A transcription and translation. Notably, NFκB can bind the HIF1A promoter and upregulate its transcription even in normoxia [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>, <a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>]. In addition, oxygen consumption in dense co-cultures may create localized hypoxia that contributes to this effect [<a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>]. More importantly, this supernatant promoted the expression of EMT-related proteins and the phosphorylation of STAT3, P13K, AKT, ERK, and NFκB in OS cells, alterations of which are vital for the malignant progression of cancers [<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a>]. We observed that, under hypoxic conditions, macrophages differentiated into the M2 type. Antibody arrays were subsequently used to screen and validate hypoxia-induced differential proteins within macrophages. Among these, the upregulation of OPN attracted our great research interest. OPN, initially identified in OS cells [<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>], is a highly glycosylated and phosphorylated protein widely distributed in tissues, cells, and body fluids. It plays crucial roles in bone metabolism, immune regulation, tumor biology, cardiovascular health, neurobiology, and gastrointestinal protection [<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a>]. Recent studies highlight the context-dependent role of OPN in OS, which may vary due to differences in OPN source, cellular context, hypoxic conditions, or tumor stage. For instance, hypoxia-induced OPN expression occurs via αvβ3 integrin–mediated GLUT1/3 upregulation, activating the FAK pathway [<a href="#CR51" class="usa-link" aria-describedby="CR51">51</a>]. IRF8 downregulation increases OPN levels, impairing T-cell activation and facilitating immune escape [<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>]. Conversely, some studies suggest that OPN downregulation inhibits mesenchymal stem cell or osteoblast maturation, potentially leading to OS [<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a>]. In our study, we specifically focused on OPN derived from hypoxia-induced M2 macrophages, which was associated with reduced expression of EGR3 and ISG15 and increased RIG-I levels in OS cells, along with activation of downstream signaling pathways. This context-dependent regulatory pattern may help explain discrepancies observed in previous studies.</p>
<p id="Par89">The hypoxia-immune-related gene signature has already been associated with the overall survival in multiple types of tumors, such as bladder cancer [<a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>], hepatocellular carcinoma [<a href="#CR55" class="usa-link" aria-describedby="CR55">55</a>], and triple-negative breast cancer [<a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>]. These studies have demonstrated that the hypoxia-immune-based genes possess high prognostic potential and clinical guidance values. Notably, our study has first identified and validated the significant upregulation of OPN in hypoxic M2 macrophage supernatants, and silencing OPN markedly reversed the stimulatory effect of these macrophages on the malignant phenotypes of OS, suggesting its pivotal role in mediating the pro-tumorigenic actions of hypoxic M2 macrophages for OS. Using HTS, we conducted an analysis of the DEGs and their enrichment in HOS cells exposed to supernatants from hypoxic M2 macrophages, uncovering a significant downregulation of EGR3-a transcription factor, pivotal in regulating gene expression during cellular differentiation, inflammatory responses, and cell migration [<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a>]. EGR3 exhibits tumor-suppressive functions in various cancers. In breast cancer, EGR3 triggered apoptosis by directly binding to the promoter of the anti-apoptotic factor MCL1 gene, facilitating its transcription [<a href="#CR58" class="usa-link" aria-describedby="CR58">58</a>]. In prostate cancer, EGR3 regulated the expression of approximately 330 genes, with 35% involved in immune responses and inflammatory processes, and 15% intersecting with the NFκB signaling pathway, and promoted prostate cancer progression by upregulating IL6 and IL8, two interleukins highly relevant to prostate cancer [<a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>]. Additionally, EGR3 regulated gene expression, transcriptionally activating zinc finger protein 36 (ZFP36), growth arrest and DNA-damage-inducible beta (GADD45B), and suppressor of cytokine signaling 3 (SOCS3) in prostate cancer, contributing to its antitumor effects [<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a>]. Here, we confirmed EGR3's inhibitory effect on OS migration. Surprisingly, EGR3 overexpression reversed the promotion effect of hypoxic M2 macrophage supernatant or OPN treatment on OS migration. Another in-depth analysis of the DEGs and their enrichment pathways uncovered the important role of OPN and EGR3 in OS immune responses. This revelation stemmed from our observations that the DEGs were predominantly enriched in various viral responses, immune system processes, and signaling pathways such as Toll-like receptor, NFκB, and RIG-I-like receptor. Furthermore, we observed that ISG15, a ubiquitin-like protein involved in antiviral immune responses [<a href="#CR61" class="usa-link" aria-describedby="CR61">61</a>], was downregulated following OPN treatment, and its overexpression significantly inhibited OS cell proliferation and migration. EGR3 overexpression reversed the pro-tumorigenic effects of OPN in vitro and in vivo, potentially through coordinated regulation of ISG15 and RIG-I. RIG-I plays a crucial role in antiviral defense and immune regulation [<a href="#CR62" class="usa-link" aria-describedby="CR62">62</a>]. Notably, ISG15 is typically induced downstream of RIG-I activation. In this study, we observed an alternative relationship wherein OPN suppresses EGR3 and ISG15, leading to increased RIG-I protein levels. This may reflect reduced ISGylation-dependent degradation of RIG-I rather than classical activation [<a href="#CR63" class="usa-link" aria-describedby="CR63">63</a>, <a href="#CR64" class="usa-link" aria-describedby="CR64">64</a>]. Given the immune regulatory role of RIG-I and the associated PD-L1 changes, our findings our findings raise the possibility that restoring EGR3 and ISG15 expression may influence RIG-I-mediated immune responses in OS, which warrants further investigation.</p>
<p id="Par90">We acknowledge several limitations in this study. First, the ectopic overexpression of EGR3 and ISG15 using a CMV promoter may not reflect physiological levels, and supraphysiological expression could have influenced some outcomes. Inducible systems or endogenous modulation strategies (e.g., CRISPRa, hypoxia mimetics) should be considered in future studies. Second, although xenograft models were used, the tumor immune microenvironment was not assessed, limiting our understanding of the ISG15/RIG-I axis in an immune context. Immunocompetent or humanized models will be needed to evaluate immune infiltration and checkpoint activity. Third, while our data suggest a correlation between OPN stimulation, ISG15 suppression, and RIG-I upregulation, direct mechanistic links remain unconfirmed. The increase in RIG-I may reflect reduced ISGylation-dependent degradation rather than classical activation, and further validation is required. Fourth, among the upregulated cytokines, only OPN was functionally characterized; other candidates merit investigation. Lastly, the therapeutic relevance of modulating OPN and its downstream regulatory interactions involving EGR3, ISG15, and RIG-I should be further evaluated in orthotopic or patient-derived models to assess long-term efficacy and safety.</p></section><section id="Sec32"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par91">This study proposed innovatively that hypoxic M2 macrophages, through OPN-dependent mechanisms, played a pivotal role in accelerating the progression of OS by inhibiting the expression of EGR3 and ISG5. This finding enhanced our understanding of OS mechanisms and offered potential therapeutic targets.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>Not applicable.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>BCA</dt>
<dd><p id="Par6">Bicinchoninic acid</p></dd>
<dt>BMDMs</dt>
<dd><p id="Par7">Bone marrow–derived macrophages</p></dd>
<dt>ChIP</dt>
<dd><p id="Par8">Chromatin immunoprecipitation</p></dd>
<dt>DEPC</dt>
<dd><p id="Par9">Diethyl pyrocarbonate</p></dd>
<dt>DMSO</dt>
<dd><p id="Par10">Dimethyl sulfoxide</p></dd>
<dt>DNMT1</dt>
<dd><p id="Par11">DNA (cytosine-5)-methyltransferase 1</p></dd>
<dt>ENA-78/CXCL5</dt>
<dd><p id="Par12">Epithelial-derived neutrophil-activating peptide 78</p></dd>
<dt>ECM</dt>
<dd><p id="Par13">Extracellular matrix</p></dd>
<dt>EGR3</dt>
<dd><p id="Par14">Early growth response 3</p></dd>
<dt>ERK</dt>
<dd><p id="Par15">Extracellular signal-regulated kinase</p></dd>
<dt>GADD45B</dt>
<dd><p id="Par16">Growth arrest and DNA-damage-inducible beta</p></dd>
<dt>GRO/CXCL1</dt>
<dd><p id="Par17">Growth-regulated oncogene</p></dd>
<dt>HIF-1α</dt>
<dd><p id="Par18">Hypoxia-inducible factor-1α</p></dd>
<dt>HIF1A</dt>
<dd><p id="Par19">Hypoxia-inducible factor 1 alpha</p></dd>
<dt>IHC</dt>
<dd><p id="Par20">Immunohistochemistry</p></dd>
<dt>IL-13</dt>
<dd><p id="Par21">Interleukin-13</p></dd>
<dt>ISG15</dt>
<dd><p id="Par22">Interferon-stimulated gene 15</p></dd>
<dt>M-CSF</dt>
<dd><p id="Par23">Macrophage colony-stimulating factor</p></dd>
<dt>MCP-1/CCL2</dt>
<dd><p id="Par24">Monocyte chemoattractant protein-1</p></dd>
<dt>MDC/CCL22</dt>
<dd><p id="Par25">Macrophage-derived chemokine</p></dd>
<dt>MTT</dt>
<dd><p id="Par26">Methylthiazolyl diphenyltetrazolium bromide</p></dd>
<dt>NFκB</dt>
<dd><p id="Par27">Nuclear factor kappa B</p></dd>
<dt>OPN</dt>
<dd><p id="Par28">Osteopontin</p></dd>
<dt>OS</dt>
<dd><p id="Par29">Osteosarcoma</p></dd>
<dt>PMA</dt>
<dd><p id="Par30">Phorbol 12-myristate 13-acetate</p></dd>
<dt>PVDF</dt>
<dd><p id="Par31">Polyvinylidene difluoride</p></dd>
<dt>PKB/AKT</dt>
<dd><p id="Par32">Protein kinase B</p></dd>
<dt>RANTES/CCL5</dt>
<dd><p id="Par33">Regulated on activation, normal T cell expressed and secreted</p></dd>
<dt>RPMI-1640</dt>
<dd><p id="Par34">Roswell Park Memorial Institute 1640</p></dd>
<dt>RT-qPCR</dt>
<dd><p id="Par35">Real-Time quantitative polymerase chain reaction</p></dd>
<dt>SOCS3</dt>
<dd><p id="Par36">Suppressor of cytokine signaling 3</p></dd>
<dt>STAT3</dt>
<dd><p id="Par37">Signal transducer and activator of transcription 3</p></dd>
<dt>TAMs</dt>
<dd><p id="Par38">Tumor-associated macrophages</p></dd>
<dt>TME</dt>
<dd><p id="Par39">Tumor microenvironment</p></dd>
<dt>TIMP-1</dt>
<dd><p id="Par40">Tissue inhibitor of metalloproteinases-1</p></dd>
<dt>TNF-α</dt>
<dd><p id="Par41">Tumor necrosis factor-alpha</p></dd>
<dt>TUNEL</dt>
<dd><p id="Par42">Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling</p></dd>
<dt>VEGF</dt>
<dd><p id="Par43">Vascular endothelial frowth factor</p></dd>
<dt>WB</dt>
<dd><p id="Par44">Western blotting</p></dd>
<dt>ZFP36</dt>
<dd><p id="Par45">Zinc finger protein 36</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>CX conceptualized the study, curated the data, conducted the investigation, and took the lead in writing the original draft and subsequent revisions. WH contributed to the conceptualization, data curation, investigation, and writing of the original draft. LZ performed the formal analysis and contributed to the methodology. All authors read and approved the final manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>All data generated or analysed during this study are included in this published article.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par92">All mice experiments were approved by the Laboratory of Animal Experimental Ethical Inspection of Dr. Can Biotechnology (Zhejiang) Co., Ltd. (Approval No. DRK-20240914021).</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par93">Not applicable.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par94">The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest, and all authors report no conflicts of interest in this work.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1">
<p><strong>Publisher's Note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div>
<div class="fn p" id="fn2"><p>Chunyang Xing and Wei Hu have contributed equally to this work.</p></div>
</div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Kansara M, Teng MW, Smyth MJ, Thomas DM. Translational biology of osteosarcoma. Nat Rev Cancer. 2014;14(11):722–35.
</cite> [<a href="https://doi.org/10.1038/nrc3838" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25319867/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kansara%20M,%20Teng%20MW,%20Smyth%20MJ,%20Thomas%20DM.%20Translational%20biology%20of%20osteosarcoma.%20Nat%20Rev%20Cancer.%202014;14(11):722%E2%80%9335." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Corre I, Verrecchia F, Crenn V, Redini F, Trichet V. The osteosarcoma microenvironment: a complex but targetable ecosystem. Cells. 2020. 10.3390/cells9040976.
</cite> [<a href="https://doi.org/10.3390/cells9040976" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7226971/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32326444/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Corre%20I,%20Verrecchia%20F,%20Crenn%20V,%20Redini%20F,%20Trichet%20V.%20The%20osteosarcoma%20microenvironment:%20a%20complex%20but%20targetable%20ecosystem.%20Cells.%202020.%2010.3390/cells9040976." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Mialou V, Philip T, Kalifa C, Perol D, Gentet JC, Marec-Berard P, et al. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome–the French pediatric experience. Cancer. 2005;104(5):1100–9.
</cite> [<a href="https://doi.org/10.1002/cncr.21263" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16015627/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mialou%20V,%20Philip%20T,%20Kalifa%20C,%20Perol%20D,%20Gentet%20JC,%20Marec-Berard%20P,%20et%20al.%20Metastatic%20osteosarcoma%20at%20diagnosis:%20prognostic%20factors%20and%20long-term%20outcome%E2%80%93the%20French%20pediatric%20experience.%20Cancer.%202005;104(5):1100%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Chen CL, Zhang L, Jiao YR, Zhou Y, Ge QF, Li PC, et al. MiR-134 inhibits osteosarcoma cell invasion and metastasis through targeting MMP1 and MMP3 in vitro and in vivo. FEBS Lett. 2019;593(10):1089–101.
</cite> [<a href="https://doi.org/10.1002/1873-3468.13387" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30977909/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20CL,%20Zhang%20L,%20Jiao%20YR,%20Zhou%20Y,%20Ge%20QF,%20Li%20PC,%20et%20al.%20MiR-134%20inhibits%20osteosarcoma%20cell%20invasion%20and%20metastasis%20through%20targeting%20MMP1%20and%20MMP3%20in%20vitro%20and%20in%20vivo.%20FEBS%20Lett.%202019;593(10):1089%E2%80%93101." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Wedekind MF, Wagner LM, Cripe TP. Immunotherapy for osteosarcoma: where do we go from here? Pediatr Blood Cancer. 2018;65(9): e27227.
</cite> [<a href="https://doi.org/10.1002/pbc.27227" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29923370/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wedekind%20MF,%20Wagner%20LM,%20Cripe%20TP.%20Immunotherapy%20for%20osteosarcoma:%20where%20do%20we%20go%20from%20here?%20Pediatr%20Blood%20Cancer.%202018;65(9):%20e27227." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Lussier DM, Johnson JL, Hingorani P, Blattman JN. Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma. J Immunother Cancer. 2015;3:21.
</cite> [<a href="https://doi.org/10.1186/s40425-015-0067-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4437699/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25992292/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lussier%20DM,%20Johnson%20JL,%20Hingorani%20P,%20Blattman%20JN.%20Combination%20immunotherapy%20with%20%CE%B1-CTLA-4%20and%20%CE%B1-PD-L1%20antibody%20blockade%20prevents%20immune%20escape%20and%20leads%20to%20complete%20control%20of%20metastatic%20osteosarcoma.%20J%20Immunother%20Cancer.%202015;3:21." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Yang C, Tian Y, Zhao F, Chen Z, Su P, Li Y, et al. Bone microenvironment and osteosarcoma metastasis. Int J Mol Sci. 2020. 10.3390/ijms21196985.
</cite> [<a href="https://doi.org/10.3390/ijms21196985" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7582690/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32977425/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20C,%20Tian%20Y,%20Zhao%20F,%20Chen%20Z,%20Su%20P,%20Li%20Y,%20et%20al.%20Bone%20microenvironment%20and%20osteosarcoma%20metastasis.%20Int%20J%20Mol%20Sci.%202020.%2010.3390/ijms21196985." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Alfranca A, Martinez-Cruzado L, Tornin J, Abarrategi A, Amaral T, de Alava E, et al. Bone microenvironment signals in osteosarcoma development. Cell Mol Life Sci CMLS. 2015;72(16):3097–113.
</cite> [<a href="https://doi.org/10.1007/s00018-015-1918-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11113487/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25935149/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alfranca%20A,%20Martinez-Cruzado%20L,%20Tornin%20J,%20Abarrategi%20A,%20Amaral%20T,%20de%20Alava%20E,%20et%20al.%20Bone%20microenvironment%20signals%20in%20osteosarcoma%20development.%20Cell%20Mol%20Life%20Sci%20CMLS.%202015;72(16):3097%E2%80%93113." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Jing X, Yang F, Shao C, Wei K, Xie M, Shen H, et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019;18(1):157.
</cite> [<a href="https://doi.org/10.1186/s12943-019-1089-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6844052/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31711497/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jing%20X,%20Yang%20F,%20Shao%20C,%20Wei%20K,%20Xie%20M,%20Shen%20H,%20et%20al.%20Role%20of%20hypoxia%20in%20cancer%20therapy%20by%20regulating%20the%20tumor%20microenvironment.%20Mol%20Cancer.%202019;18(1):157." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Roma-Rodrigues C, Mendes R, Baptista PV, Fernandes AR. Targeting tumor microenvironment for cancer therapy. Int J Mol Sci. 2019. 10.3390/ijms20040840.
</cite> [<a href="https://doi.org/10.3390/ijms20040840" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6413095/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30781344/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Roma-Rodrigues%20C,%20Mendes%20R,%20Baptista%20PV,%20Fernandes%20AR.%20Targeting%20tumor%20microenvironment%20for%20cancer%20therapy.%20Int%20J%20Mol%20Sci.%202019.%2010.3390/ijms20040840." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G. Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res. 2000;60(17):4693–6.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/10987269/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Birner%20P,%20Schindl%20M,%20Obermair%20A,%20Plank%20C,%20Breitenecker%20G,%20Oberhuber%20G.%20Overexpression%20of%20hypoxia-inducible%20factor%201alpha%20is%20a%20marker%20for%20an%20unfavorable%20prognosis%20in%20early-stage%20invasive%20cervical%20cancer.%20Cancer%20Res.%202000;60(17):4693%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L. Macrophages and metabolism in the tumor microenvironment. Cell Metab. 2019;30(1):36–50.
</cite> [<a href="https://doi.org/10.1016/j.cmet.2019.06.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31269428/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vitale%20I,%20Manic%20G,%20Coussens%20LM,%20Kroemer%20G,%20Galluzzi%20L.%20Macrophages%20and%20metabolism%20in%20the%20tumor%20microenvironment.%20Cell%20Metab.%202019;30(1):36%E2%80%9350." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol. 2017;14(7):399–416.
</cite> [<a href="https://doi.org/10.1038/nrclinonc.2016.217" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5480600/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28117416/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mantovani%20A,%20Marchesi%20F,%20Malesci%20A,%20Laghi%20L,%20Allavena%20P.%20Tumour-associated%20macrophages%20as%20treatment%20targets%20in%20oncology.%20Nat%20Rev%20Clin%20Oncol.%202017;14(7):399%E2%80%93416." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Sattiraju A, Kang S, Giotti B, Chen Z, Marallano VJ, Brusco C, et al. Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression. Immunity. 2023;56(8):1825-43.e6.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2023.06.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10527169/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37451265/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sattiraju%20A,%20Kang%20S,%20Giotti%20B,%20Chen%20Z,%20Marallano%20VJ,%20Brusco%20C,%20et%20al.%20Hypoxic%20niches%20attract%20and%20sequester%20tumor-associated%20macrophages%20and%20cytotoxic%20T%20cells%20and%20reprogram%20them%20for%20immunosuppression.%20Immunity.%202023;56(8):1825-43.e6." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Zhu G, Tang Y, Geng N, Zheng M, Jiang J, Li L, et al. HIF-α/MIF and NF-κB/IL-6 axes contribute to the recruitment of CD11b+Gr-1+ myeloid cells in hypoxic microenvironment of HNSCC. Neoplasia (New York, NY). 2014;16(2):168–79.</cite> [<a href="https://doi.org/10.1593/neo.132034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3978397/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24709424/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhu%20G,%20Tang%20Y,%20Geng%20N,%20Zheng%20M,%20Jiang%20J,%20Li%20L,%20et%20al.%20HIF-%CE%B1/MIF%20and%20NF-%CE%BAB/IL-6%20axes%20contribute%20to%20the%20recruitment%20of%20CD11b+Gr-1+%20myeloid%20cells%20in%20hypoxic%20microenvironment%20of%20HNSCC.%20Neoplasia%20(New%20York,%20NY).%202014;16(2):168%E2%80%9379." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Zhang W, Lyu P, Andreev D, Jia Y, Zhang F, Bozec A. Hypoxia-immune-related microenvironment prognostic signature for osteosarcoma. Front Cell Dev Biol. 2022;10: 974851.
</cite> [<a href="https://doi.org/10.3389/fcell.2022.974851" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9791087/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36578780/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20W,%20Lyu%20P,%20Andreev%20D,%20Jia%20Y,%20Zhang%20F,%20Bozec%20A.%20Hypoxia-immune-related%20microenvironment%20prognostic%20signature%20for%20osteosarcoma.%20Front%20Cell%20Dev%20Biol.%202022;10:%20974851." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Pierrevelcin M, Flacher V, Mueller CG, Vauchelles R, Guerin E, Lhermitte B, et al. Engineering novel 3D models to recreate high-grade osteosarcoma and its immune and extracellular matrix microenvironment. Adv Healthcare Mater. 2022;11(19): e2200195.</cite> [<a href="https://doi.org/10.1002/adhm.202200195" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36057996/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pierrevelcin%20M,%20Flacher%20V,%20Mueller%20CG,%20Vauchelles%20R,%20Guerin%20E,%20Lhermitte%20B,%20et%20al.%20Engineering%20novel%203D%20models%20to%20recreate%20high-grade%20osteosarcoma%20and%20its%20immune%20and%20extracellular%20matrix%20microenvironment.%20Adv%20Healthcare%20Mater.%202022;11(19):%20e2200195." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Ma J, Guo Z, Yang X, Zhu Y. Exploration of various roles of hypoxia genes in osteosarcoma. Sci Rep. 2022;12(1):18293.
</cite> [<a href="https://doi.org/10.1038/s41598-022-17622-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9622735/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36316355/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ma%20J,%20Guo%20Z,%20Yang%20X,%20Zhu%20Y.%20Exploration%20of%20various%20roles%20of%20hypoxia%20genes%20in%20osteosarcoma.%20Sci%20Rep.%202022;12(1):18293." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Kurien BT, Scofield RH. Validating antibody specificities for immunohistochemistry by protein blotting methods. Methods Mol Biol (Clifton, NJ). 2017;1554:61–73.</cite> [<a href="https://doi.org/10.1007/978-1-4939-6759-9_3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28185183/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kurien%20BT,%20Scofield%20RH.%20Validating%20antibody%20specificities%20for%20immunohistochemistry%20by%20protein%20blotting%20methods.%20Methods%20Mol%20Biol%20(Clifton,%20NJ).%202017;1554:61%E2%80%9373." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Zhao C, Zhang Q, Yu T, Sun S, Wang W, Liu G. Hypoxia promotes drug resistance in osteosarcoma cells via activating AMP-activated protein kinase (AMPK) signaling. J Bone Oncol. 2016;5(1):22–9.
</cite> [<a href="https://doi.org/10.1016/j.jbo.2016.01.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4782021/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26998423/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20C,%20Zhang%20Q,%20Yu%20T,%20Sun%20S,%20Wang%20W,%20Liu%20G.%20Hypoxia%20promotes%20drug%20resistance%20in%20osteosarcoma%20cells%20via%20activating%20AMP-activated%20protein%20kinase%20(AMPK)%20signaling.%20J%20Bone%20Oncol.%202016;5(1):22%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Choi HJ, Song BJ, Gong YD, Gwak WJ, Soh Y. Rapid degradation of hypoxia-inducible factor-1alpha by KRH102053, a new activator of prolyl hydroxylase 2. Br J Pharmacol. 2008;154(1):114–25.
</cite> [<a href="https://doi.org/10.1038/bjp.2008.70" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2438970/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18332861/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Choi%20HJ,%20Song%20BJ,%20Gong%20YD,%20Gwak%20WJ,%20Soh%20Y.%20Rapid%20degradation%20of%20hypoxia-inducible%20factor-1alpha%20by%20KRH102053,%20a%20new%20activator%20of%20prolyl%20hydroxylase%202.%20Br%20J%20Pharmacol.%202008;154(1):114%E2%80%9325." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Li YS, Deng ZH, Zeng C, Lei GH. Role of osteopontin in osteosarcoma. Med Oncol. 2015;32(1):449.
</cite> [<a href="https://doi.org/10.1007/s12032-014-0449-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25516504/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20YS,%20Deng%20ZH,%20Zeng%20C,%20Lei%20GH.%20Role%20of%20osteopontin%20in%20osteosarcoma.%20Med%20Oncol.%202015;32(1):449." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Shao Z, Bi S. Endocrine regulation and metabolic mechanisms of osteopontin in the development and progression of osteosarcoma, metastasis and prognosis. Front Endocrinol (Lausanne). 2022;13: 1100063.
</cite> [<a href="https://doi.org/10.3389/fendo.2022.1100063" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9880040/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36714568/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shao%20Z,%20Bi%20S.%20Endocrine%20regulation%20and%20metabolic%20mechanisms%20of%20osteopontin%20in%20the%20development%20and%20progression%20of%20osteosarcoma,%20metastasis%20and%20prognosis.%20Front%20Endocrinol%20(Lausanne).%202022;13:%201100063." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Chiang C, Liu G, Gack MU. Viral evasion of RIG-I-like receptor-mediated immunity through dysregulation of ubiquitination and ISGylation. Viruses. 2021. 10.3390/v13020182.
</cite> [<a href="https://doi.org/10.3390/v13020182" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7910861/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33530371/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chiang%20C,%20Liu%20G,%20Gack%20MU.%20Viral%20evasion%20of%20RIG-I-like%20receptor-mediated%20immunity%20through%20dysregulation%20of%20ubiquitination%20and%20ISGylation.%20Viruses.%202021.%2010.3390/v13020182." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Wardlaw CP, Petrini JHJ. ISG15: a link between innate immune signaling, DNA replication, and genome stability. BioEssays. 2023;45(7): e2300042.
</cite> [<a href="https://doi.org/10.1002/bies.202300042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10473822/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37147792/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wardlaw%20CP,%20Petrini%20JHJ.%20ISG15:%20a%20link%20between%20innate%20immune%20signaling,%20DNA%20replication,%20and%20genome%20stability.%20BioEssays.%202023;45(7):%20e2300042." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Wu SF, Xia L, Shi XD, Dai YJ, Zhang WN, Zhao JM, et al. RIG-I regulates myeloid differentiation by promoting TRIM25-mediated ISGylation. Proc Natl Acad Sci U S A. 2020;117(25):14395–404.
</cite> [<a href="https://doi.org/10.1073/pnas.1918596117" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7322067/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32513696/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20SF,%20Xia%20L,%20Shi%20XD,%20Dai%20YJ,%20Zhang%20WN,%20Zhao%20JM,%20et%20al.%20RIG-I%20regulates%20myeloid%20differentiation%20by%20promoting%20TRIM25-mediated%20ISGylation.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202020;117(25):14395%E2%80%93404." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci U S A. 2005;102(29):10200–5.
</cite> [<a href="https://doi.org/10.1073/pnas.0504754102" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1177427/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16009940/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao%20C,%20Denison%20C,%20Huibregtse%20JM,%20Gygi%20S,%20Krug%20RM.%20Human%20ISG15%20conjugation%20targets%20both%20IFN-induced%20and%20constitutively%20expressed%20proteins%20functioning%20in%20diverse%20cellular%20pathways.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%202005;102(29):10200%E2%80%935." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Zhang Y, Zeng L, Wang M, Yang Z, Zhang H, Gao L, et al. RIG-I promotes immune evasion of colon cancer by modulating PD-L1 ubiquitination. J Immunother Cancer. 2023. 10.1136/jitc-2023-007313.
</cite> [<a href="https://doi.org/10.1136/jitc-2023-007313" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10537859/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37758653/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20Y,%20Zeng%20L,%20Wang%20M,%20Yang%20Z,%20Zhang%20H,%20Gao%20L,%20et%20al.%20RIG-I%20promotes%20immune%20evasion%20of%20colon%20cancer%20by%20modulating%20PD-L1%20ubiquitination.%20J%20Immunother%20Cancer.%202023.%2010.1136/jitc-2023-007313." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Li XY, Guo HZ, Zhu J. Tumor suppressor activity of RIG-I. Mol Cell Oncol. 2014;1(4): e968016.
</cite> [<a href="https://doi.org/10.4161/23723548.2014.968016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4905202/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27308362/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20XY,%20Guo%20HZ,%20Zhu%20J.%20Tumor%20suppressor%20activity%20of%20RIG-I.%20Mol%20Cell%20Oncol.%202014;1(4):%20e968016." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Deng Y, Fu H, Han X, Li Y, Zhao W, Zhao X, et al. Activation of DDX58/RIG-I suppresses the growth of tumor cells by inhibiting STAT3/CSE signaling in colon cancer. Int J Oncol. 2022. 10.3892/ijo.2022.5410.
</cite> [<a href="https://doi.org/10.3892/ijo.2022.5410" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9450811/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36004488/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Deng%20Y,%20Fu%20H,%20Han%20X,%20Li%20Y,%20Zhao%20W,%20Zhao%20X,%20et%20al.%20Activation%20of%20DDX58/RIG-I%20suppresses%20the%20growth%20of%20tumor%20cells%20by%20inhibiting%20STAT3/CSE%20signaling%20in%20colon%20cancer.%20Int%20J%20Oncol.%202022.%2010.3892/ijo.2022.5410." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Brägelmann J, Lorenz C, Borchmann S, Nishii K, Wegner J, Meder L, et al. Mapk-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I. Nat Commun. 2021;12(1):5505.
</cite> [<a href="https://doi.org/10.1038/s41467-021-25728-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8448826/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34535668/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Br%C3%A4gelmann%20J,%20Lorenz%20C,%20Borchmann%20S,%20Nishii%20K,%20Wegner%20J,%20Meder%20L,%20et%20al.%20Mapk-pathway%20inhibition%20mediates%20inflammatory%20reprogramming%20and%20sensitizes%20tumors%20to%20targeted%20activation%20of%20innate%20immunity%20sensor%20RIG-I.%20Nat%20Commun.%202021;12(1):5505." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Chen Z, Zhang Y. Role of mammalian DNA methyltransferases in development. Annu Rev Biochem. 2020;89:135–58.
</cite> [<a href="https://doi.org/10.1146/annurev-biochem-103019-102815" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31815535/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20Z,%20Zhang%20Y.%20Role%20of%20mammalian%20DNA%20methyltransferases%20in%20development.%20Annu%20Rev%20Biochem.%202020;89:135%E2%80%9358." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Wang Z, Li B, Li S, Lin W, Wang Z, Wang S, et al. Metabolic control of CD47 expression through LAT2-mediated amino acid uptake promotes tumor immune evasion. Nat Commun. 2022;13(1):6308.
</cite> [<a href="https://doi.org/10.1038/s41467-022-34064-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9588779/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36274066/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Z,%20Li%20B,%20Li%20S,%20Lin%20W,%20Wang%20Z,%20Wang%20S,%20et%20al.%20Metabolic%20control%20of%20CD47%20expression%20through%20LAT2-mediated%20amino%20acid%20uptake%20promotes%20tumor%20immune%20evasion.%20Nat%20Commun.%202022;13(1):6308." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Guan G, Zhang Y, Lu Y, Liu L, Shi D, Wen Y, et al. The HIF-1α/CXCR4 pathway supports hypoxia-induced metastasis of human osteosarcoma cells. Cancer Lett. 2015;357(1):254–64.
</cite> [<a href="https://doi.org/10.1016/j.canlet.2014.11.034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25444927/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guan%20G,%20Zhang%20Y,%20Lu%20Y,%20Liu%20L,%20Shi%20D,%20Wen%20Y,%20et%20al.%20The%20HIF-1%CE%B1/CXCR4%20pathway%20supports%20hypoxia-induced%20metastasis%20of%20human%20osteosarcoma%20cells.%20Cancer%20Lett.%202015;357(1):254%E2%80%9364." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Jiang F, Miao XL, Zhang XT, Yan F, Mao Y, Wu CY, et al. A hypoxia gene-based signature to predict the survival and affect the tumor immune microenvironment of osteosarcoma in children. J Immunol Res. 2021;2021:5523832.
</cite> [<a href="https://doi.org/10.1155/2021/5523832" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8299210/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34337075/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jiang%20F,%20Miao%20XL,%20Zhang%20XT,%20Yan%20F,%20Mao%20Y,%20Wu%20CY,%20et%20al.%20A%20hypoxia%20gene-based%20signature%20to%20predict%20the%20survival%20and%20affect%20the%20tumor%20immune%20microenvironment%20of%20osteosarcoma%20in%20children.%20J%20Immunol%20Res.%202021;2021:5523832." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Han T, Wu Z, Zhang Z, Liang J, Xia C, Yan H. Comprehensive analysis of hypoxia-related genes for prognosis value, immune status, and therapy in osteosarcoma patients. Front Pharmacol. 2022;13: 1088732.
</cite> [<a href="https://doi.org/10.3389/fphar.2022.1088732" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9853159/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36686667/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Han%20T,%20Wu%20Z,%20Zhang%20Z,%20Liang%20J,%20Xia%20C,%20Yan%20H.%20Comprehensive%20analysis%20of%20hypoxia-related%20genes%20for%20prognosis%20value,%20immune%20status,%20and%20therapy%20in%20osteosarcoma%20patients.%20Front%20Pharmacol.%202022;13:%201088732." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Xiao B, Liu L, Li A, Xiang C, Wang P, Li H, et al. Identification and verification of immune-related gene prognostic signature based on ssGSEA for osteosarcoma. Front Oncol. 2020;10: 607622.
</cite> [<a href="https://doi.org/10.3389/fonc.2020.607622" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7771722/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33384961/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xiao%20B,%20Liu%20L,%20Li%20A,%20Xiang%20C,%20Wang%20P,%20Li%20H,%20et%20al.%20Identification%20and%20verification%20of%20immune-related%20gene%20prognostic%20signature%20based%20on%20ssGSEA%20for%20osteosarcoma.%20Front%20Oncol.%202020;10:%20607622." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Zhang C, Zheng JH, Lin ZH, Lv HY, Ye ZM, Chen YP, et al. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma. Aging. 2020;12(4):3486–501.
</cite> [<a href="https://doi.org/10.18632/aging.102824" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7066877/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32039832/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20C,%20Zheng%20JH,%20Lin%20ZH,%20Lv%20HY,%20Ye%20ZM,%20Chen%20YP,%20et%20al.%20Profiles%20of%20immune%20cell%20infiltration%20and%20immune-related%20genes%20in%20the%20tumor%20microenvironment%20of%20osteosarcoma.%20Aging.%202020;12(4):3486%E2%80%93501." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Fu Y, Bao Q, Liu Z, He G, Wen J, Liu Q, et al. Development and validation of a hypoxia-associated prognostic signature related to osteosarcoma metastasis and immune infiltration. Front Cell Dev Biol. 2021;9: 633607.
</cite> [<a href="https://doi.org/10.3389/fcell.2021.633607" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8012854/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33816483/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fu%20Y,%20Bao%20Q,%20Liu%20Z,%20He%20G,%20Wen%20J,%20Liu%20Q,%20et%20al.%20Development%20and%20validation%20of%20a%20hypoxia-associated%20prognostic%20signature%20related%20to%20osteosarcoma%20metastasis%20and%20immune%20infiltration.%20Front%20Cell%20Dev%20Biol.%202021;9:%20633607." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Ocadlikova D, Lecciso M, Broto JM, Scotlandi K, Cavo M, Curti A, et al. Sunitinib exerts in vitro immunomodulatory activity on sarcomas via dendritic cells and synergizes with PD-1 blockade. Front Immunol. 2021;12: 577766.
</cite> [<a href="https://doi.org/10.3389/fimmu.2021.577766" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7952316/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33717062/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ocadlikova%20D,%20Lecciso%20M,%20Broto%20JM,%20Scotlandi%20K,%20Cavo%20M,%20Curti%20A,%20et%20al.%20Sunitinib%20exerts%20in%20vitro%20immunomodulatory%20activity%20on%20sarcomas%20via%20dendritic%20cells%20and%20synergizes%20with%20PD-1%20blockade.%20Front%20Immunol.%202021;12:%20577766." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Gao Y, Wang Z, Jin X, Wang X, Tao Y, Huang S, et al. Enhanced osteosarcoma immunotherapy via CaCO(3) nanoparticles: remodeling tumor acidic and immune microenvironment for photodynamic therapy. Adv Healthcare Mater. 2024;13(23): e2400538.</cite> [<a href="https://doi.org/10.1002/adhm.202400538" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38759954/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gao%20Y,%20Wang%20Z,%20Jin%20X,%20Wang%20X,%20Tao%20Y,%20Huang%20S,%20et%20al.%20Enhanced%20osteosarcoma%20immunotherapy%20via%20CaCO(3)%20nanoparticles:%20remodeling%20tumor%20acidic%20and%20immune%20microenvironment%20for%20photodynamic%20therapy.%20Adv%20Healthcare%20Mater.%202024;13(23):%20e2400538." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Endo-Munoz L, Cumming A, Sommerville S, Dickinson I, Saunders NA. Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone. Br J Cancer. 2010;103(1):73–81.
</cite> [<a href="https://doi.org/10.1038/sj.bjc.6605723" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2905286/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20551950/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Endo-Munoz%20L,%20Cumming%20A,%20Sommerville%20S,%20Dickinson%20I,%20Saunders%20NA.%20Osteosarcoma%20is%20characterised%20by%20reduced%20expression%20of%20markers%20of%20osteoclastogenesis%20and%20antigen%20presentation%20compared%20with%20normal%20bone.%20Br%20J%20Cancer.%202010;103(1):73%E2%80%9381." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Yang SY, Garcia E, Xia W, Wang A. Effects of hypoxia on proliferation and apoptosis of osteosarcoma cells. Anticancer Res. 2021;41(10):4781–7.
</cite> [<a href="https://doi.org/10.21873/anticanres.15293" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34593427/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang%20SY,%20Garcia%20E,%20Xia%20W,%20Wang%20A.%20Effects%20of%20hypoxia%20on%20proliferation%20and%20apoptosis%20of%20osteosarcoma%20cells.%20Anticancer%20Res.%202021;41(10):4781%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Ma Q, Zhang Y, Liu T, Jiang K, Wen Y, Fan Q, et al. Hypoxia promotes chemotherapy resistance by down-regulating SKA1 gene expression in human osteosarcoma. Cancer Biol Ther. 2017;18(3):177–85.
</cite> [<a href="https://doi.org/10.1080/15384047.2017.1294285" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5389426/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28278080/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ma%20Q,%20Zhang%20Y,%20Liu%20T,%20Jiang%20K,%20Wen%20Y,%20Fan%20Q,%20et%20al.%20Hypoxia%20promotes%20chemotherapy%20resistance%20by%20down-regulating%20SKA1%20gene%20expression%20in%20human%20osteosarcoma.%20Cancer%20Biol%20Ther.%202017;18(3):177%E2%80%9385." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Kumar S, Mehta K. Tissue transglutaminase constitutively activates HIF-1α promoter and nuclear factor-κB via a non-canonical pathway. PLoS ONE. 2012;7(11): e49321.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0049321" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3501523/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23185316/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kumar%20S,%20Mehta%20K.%20Tissue%20transglutaminase%20constitutively%20activates%20HIF-1%CE%B1%20promoter%20and%20nuclear%20factor-%CE%BAB%20via%20a%20non-canonical%20pathway.%20PLoS%20ONE.%202012;7(11):%20e49321." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Zhang J, Yao M, Xia S, Zeng F, Liu Q. Systematic and comprehensive insights into HIF-1 stabilization under normoxic conditions: implications for cellular adaptation and therapeutic strategies in cancer. Cell Mol Biol Lett. 2025;30(1):2.
</cite> [<a href="https://doi.org/10.1186/s11658-024-00682-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11702238/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39757165/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20J,%20Yao%20M,%20Xia%20S,%20Zeng%20F,%20Liu%20Q.%20Systematic%20and%20comprehensive%20insights%20into%20HIF-1%20stabilization%20under%20normoxic%20conditions:%20implications%20for%20cellular%20adaptation%20and%20therapeutic%20strategies%20in%20cancer.%20Cell%20Mol%20Biol%20Lett.%202025;30(1):2." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Tan J, Virtue S, Norris DM, Conway OJ, Yang M, Bidault G, et al. Limited oxygen in standard cell culture alters metabolism and function of differentiated cells. EMBO J. 2024;43(11):2127–65.
</cite> [<a href="https://doi.org/10.1038/s44318-024-00084-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11148168/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38580776/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tan%20J,%20Virtue%20S,%20Norris%20DM,%20Conway%20OJ,%20Yang%20M,%20Bidault%20G,%20et%20al.%20Limited%20oxygen%20in%20standard%20cell%20culture%20alters%20metabolism%20and%20function%20of%20differentiated%20cells.%20EMBO%20J.%202024;43(11):2127%E2%80%9365." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Girisa S, Saikia Q, Bordoloi D, Banik K, Monisha J, Daimary UD, et al. Xanthohumol from hop: hope for cancer prevention and treatment. IUBMB Life. 2021;73(8):1016–44.
</cite> [<a href="https://doi.org/10.1002/iub.2522" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34170599/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Girisa%20S,%20Saikia%20Q,%20Bordoloi%20D,%20Banik%20K,%20Monisha%20J,%20Daimary%20UD,%20et%20al.%20Xanthohumol%20from%20hop:%20hope%20for%20cancer%20prevention%20and%20treatment.%20IUBMB%20Life.%202021;73(8):1016%E2%80%9344." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Oldberg A, Franzén A, Heinegård D. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci U S A. 1986;83(23):8819–23.
</cite> [<a href="https://doi.org/10.1073/pnas.83.23.8819" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC387024/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3024151/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Oldberg%20A,%20Franz%C3%A9n%20A,%20Heineg%C3%A5rd%20D.%20Cloning%20and%20sequence%20analysis%20of%20rat%20bone%20sialoprotein%20(osteopontin)%20cDNA%20reveals%20an%20Arg-Gly-Asp%20cell-binding%20sequence.%20Proc%20Natl%20Acad%20Sci%20U%20S%20A.%201986;83(23):8819%E2%80%9323." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Rittling SR, Chambers AF. Role of osteopontin in tumour progression. Br J Cancer. 2004;90(10):1877–81.
</cite> [<a href="https://doi.org/10.1038/sj.bjc.6601839" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2410284/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15138464/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rittling%20SR,%20Chambers%20AF.%20Role%20of%20osteopontin%20in%20tumour%20progression.%20Br%20J%20Cancer.%202004;90(10):1877%E2%80%9381." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Hsieh IS, Yang RS, Fu WM. Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells. PLoS ONE. 2014;9(10): e109550.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0109550" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4195676/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25310823/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hsieh%20IS,%20Yang%20RS,%20Fu%20WM.%20Osteopontin%20upregulates%20the%20expression%20of%20glucose%20transporters%20in%20osteosarcoma%20cells.%20PLoS%20ONE.%202014;9(10):%20e109550." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Klement JD, Paschall AV, Redd PS, Ibrahim ML, Lu C, Yang D, et al. An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion. J Clin Invest. 2018;128(12):5549–60.
</cite> [<a href="https://doi.org/10.1172/JCI123360" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6264631/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30395540/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Klement%20JD,%20Paschall%20AV,%20Redd%20PS,%20Ibrahim%20ML,%20Lu%20C,%20Yang%20D,%20et%20al.%20An%20osteopontin/CD44%20immune%20checkpoint%20controls%20CD8+%20T%20cell%20activation%20and%20tumor%20immune%20evasion.%20J%20Clin%20Invest.%202018;128(12):5549%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Luo X, Chen J, Song WX, Tang N, Luo J, Deng ZL, et al. Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects. Lab Invest. 2008;88(12):1264–77.
</cite> [<a href="https://doi.org/10.1038/labinvest.2008.98" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9901484/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18838962/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Luo%20X,%20Chen%20J,%20Song%20WX,%20Tang%20N,%20Luo%20J,%20Deng%20ZL,%20et%20al.%20Osteogenic%20BMPs%20promote%20tumor%20growth%20of%20human%20osteosarcomas%20that%20harbor%20differentiation%20defects.%20Lab%20Invest.%202008;88(12):1264%E2%80%9377." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Smith V, Lee D, Reardon M, Shabbir R, Sahoo S, Hoskin P, et al. Hypoxia is associated with increased immune infiltrates and both anti-tumour and immune suppressive signalling in muscle-invasive bladder cancer. Int J Mol Sci. 2023. 10.3390/ijms24108956.
</cite> [<a href="https://doi.org/10.3390/ijms24108956" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10219458/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37240301/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Smith%20V,%20Lee%20D,%20Reardon%20M,%20Shabbir%20R,%20Sahoo%20S,%20Hoskin%20P,%20et%20al.%20Hypoxia%20is%20associated%20with%20increased%20immune%20infiltrates%20and%20both%20anti-tumour%20and%20immune%20suppressive%20signalling%20in%20muscle-invasive%20bladder%20cancer.%20Int%20J%20Mol%20Sci.%202023.%2010.3390/ijms24108956." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Fu Y, Mackowiak B, Feng D, Lu H, Guan Y, Lehner T, et al. Microrna-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression. Gut. 2023;72(10):1942–58.
</cite> [<a href="https://doi.org/10.1136/gutjnl-2022-327924" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11283862/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36593103/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fu%20Y,%20Mackowiak%20B,%20Feng%20D,%20Lu%20H,%20Guan%20Y,%20Lehner%20T,%20et%20al.%20Microrna-223%20attenuates%20hepatocarcinogenesis%20by%20blocking%20hypoxia-driven%20angiogenesis%20and%20immunosuppression.%20Gut.%202023;72(10):1942%E2%80%9358." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Ma S, Zhao Y, Lee WC, Ong LT, Lee PL, Jiang Z, et al. Hypoxia induces HIF1α-dependent epigenetic vulnerability in triple negative breast cancer to confer immune effector dysfunction and resistance to anti-PD-1 immunotherapy. Nat Commun. 2022;13(1):4118.
</cite> [<a href="https://doi.org/10.1038/s41467-022-31764-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9287350/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35840558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ma%20S,%20Zhao%20Y,%20Lee%20WC,%20Ong%20LT,%20Lee%20PL,%20Jiang%20Z,%20et%20al.%20Hypoxia%20induces%20HIF1%CE%B1-dependent%20epigenetic%20vulnerability%20in%20triple%20negative%20breast%20cancer%20to%20confer%20immune%20effector%20dysfunction%20and%20resistance%20to%20anti-PD-1%20immunotherapy.%20Nat%20Commun.%202022;13(1):4118." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Chen CH, Chen Y, Li YN, Zhang H, Huang X, Li YY, et al. EGR3 inhibits tumor progression by inducing Schwann cell-like differentiation. Adv Sci (Weinheim, Baden-Wurttemberg, Germany). 2024;11(34): e2400066.</cite> [<a href="https://doi.org/10.1002/advs.202400066" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11425834/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38973154/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen%20CH,%20Chen%20Y,%20Li%20YN,%20Zhang%20H,%20Huang%20X,%20Li%20YY,%20et%20al.%20EGR3%20inhibits%20tumor%20progression%20by%20inducing%20Schwann%20cell-like%20differentiation.%20Adv%20Sci%20(Weinheim,%20Baden-Wurttemberg,%20Germany).%202024;11(34):%20e2400066." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Xie Y, Han X, Yu J, Yuan M, Yan Y, Qin J, et al. EGR3 and estrone are involved in the tamoxifen resistance and progression of breast cancer. J Cancer Res Clin Oncol. 2023;149(20):18103–17.
</cite> [<a href="https://doi.org/10.1007/s00432-023-05503-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11798252/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37999751/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xie%20Y,%20Han%20X,%20Yu%20J,%20Yuan%20M,%20Yan%20Y,%20Qin%20J,%20et%20al.%20EGR3%20and%20estrone%20are%20involved%20in%20the%20tamoxifen%20resistance%20and%20progression%20of%20breast%20cancer.%20J%20Cancer%20Res%20Clin%20Oncol.%202023;149(20):18103%E2%80%9317." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Baron VT, Pio R, Jia Z, Mercola D. Early growth response 3 regulates genes of inflammation and directly activates IL6 and IL8 expression in prostate cancer. Br J Cancer. 2015;112(4):755–64.
</cite> [<a href="https://doi.org/10.1038/bjc.2014.622" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4333488/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25633035/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Baron%20VT,%20Pio%20R,%20Jia%20Z,%20Mercola%20D.%20Early%20growth%20response%203%20regulates%20genes%20of%20inflammation%20and%20directly%20activates%20IL6%20and%20IL8%20expression%20in%20prostate%20cancer.%20Br%20J%20Cancer.%202015;112(4):755%E2%80%9364." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Shin SH, Kim I, Lee JE, Lee M, Park JW. Loss of EGR3 is an independent risk factor for metastatic progression in prostate cancer. Oncogene. 2020;39(36):5839–54.
</cite> [<a href="https://doi.org/10.1038/s41388-020-01418-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32796959/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shin%20SH,%20Kim%20I,%20Lee%20JE,%20Lee%20M,%20Park%20JW.%20Loss%20of%20EGR3%20is%20an%20independent%20risk%20factor%20for%20metastatic%20progression%20in%20prostate%20cancer.%20Oncogene.%202020;39(36):5839%E2%80%9354." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Perng YC, Lenschow DJ. ISG15 in antiviral immunity and beyond. Nat Rev Microbiol. 2018;16(7):423–39.
</cite> [<a href="https://doi.org/10.1038/s41579-018-0020-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7097117/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29769653/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Perng%20YC,%20Lenschow%20DJ.%20ISG15%20in%20antiviral%20immunity%20and%20beyond.%20Nat%20Rev%20Microbiol.%202018;16(7):423%E2%80%9339." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR62">
<span class="label">62.</span><cite>Jiang Y, Zhang H, Wang J, Chen J, Guo Z, Liu Y, et al. Exploiting RIG-I-like receptor pathway for cancer immunotherapy. J Hematol Oncol. 2023;16(1):8.
</cite> [<a href="https://doi.org/10.1186/s13045-023-01405-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9906624/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36755342/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jiang%20Y,%20Zhang%20H,%20Wang%20J,%20Chen%20J,%20Guo%20Z,%20Liu%20Y,%20et%20al.%20Exploiting%20RIG-I-like%20receptor%20pathway%20for%20cancer%20immunotherapy.%20J%20Hematol%20Oncol.%202023;16(1):8." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<span class="label">63.</span><cite>Kim MJ, Hwang SY, Imaizumi T, Yoo JY. Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J Virol. 2008;82(3):1474–83.
</cite> [<a href="https://doi.org/10.1128/JVI.01650-07" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2224411/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18057259/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20MJ,%20Hwang%20SY,%20Imaizumi%20T,%20Yoo%20JY.%20Negative%20feedback%20regulation%20of%20RIG-I-mediated%20antiviral%20signaling%20by%20interferon-induced%20ISG15%20conjugation.%20J%20Virol.%202008;82(3):1474%E2%80%9383." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<span class="label">64.</span><cite>Wang Y, Feng H, Li X, Ruan Y, Guo Y, Cui X, et al. Dampening of ISGylation of RIG-I by ADAP regulates type I interferon response of macrophages to RNA virus infection. PLoS Pathog. 2024;20(5): e1012230.
</cite> [<a href="https://doi.org/10.1371/journal.ppat.1012230" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11111093/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38776321/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang%20Y,%20Feng%20H,%20Li%20X,%20Ruan%20Y,%20Guo%20Y,%20Cui%20X,%20et%20al.%20Dampening%20of%20ISGylation%20of%20RIG-I%20by%20ADAP%20regulates%20type%20I%20interferon%20response%20of%20macrophages%20to%20RNA%20virus%20infection.%20PLoS%20Pathog.%202024;20(5):%20e1012230." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>All data generated or analysed during this study are included in this published article.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Journal of Translational Medicine are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s12967-025-06936-y"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/12967_2025_Article_6936.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (7.5 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12372297/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12372297/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372297%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372297/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12372297/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12372297/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40841904/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12372297/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40841904/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12372297/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12372297/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="cxjHlFIv9pzqH8vhPHot1bfIApNi5gJmNjNPSN9zkPR68pY7F8Ed2LAnryNh7NG2">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
